Online citations, reference lists, and bibliographies.
← Back to Search

Cancer Diagnostics

J. Wu, R. Nagle
Published 2004 ·

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/S0167-7799(01)01814-5
Personalized medicine: revolutionizing drug discovery and patient care.
G. Ginsburg (2001)
10.1097/00000372-199810000-00018
CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin.
N. Uchiyama (1998)
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.
G. Pauletti (1996)
10.1016/0958-1669(92)90006-5
Molecular cytogenetics: diagnosis and prognostic assessment.
J. Gray (1992)
10.1056/NEJM199502163320704
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
J. Brennan (1995)
10.3892/IJO.19.6.1319
Methylation profiling of human cancers in blood: molecular monitoring and prognostication (review).
I. Wong (2001)
Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
M. Press (1994)
10.2307/2531985
Flow cytometry : instrumentation and data analysis
Van Dill (1987)
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
T. Rebbeck (1996)
10.1007/978-3-642-66800-5_1
Human papillomaviruses and their possible role in squamous cell carcinomas.
H. Hausen (1977)
10.1038/nrm760
Messenger-RNA-binding proteins and the messages they carry
G. Dreyfuss (2002)
ATM mutations in cancer families.
I. Vorechovsky (1996)
10.1046/j.1365-2141.2000.01989.x
The Current Status of Lymphoma Classification
P. Isaacson (2000)
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
C. Wright (1989)
10.1182/BLOOD.V89.4.1394
Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
K. Pulford (1997)
10.1034/j.1399-0004.2001.590201.x
Advances in the detection of chromosomal aberrations using spectral karyotyping
J. Bayani (2001)
10.1093/OXFORDJOURNALS.QJMED.A068657
Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals.
C. Woods (1992)
10.1093/JNCI/77.1.89
Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.
D. Morrell (1986)
10.2174/1566524013364121
Microdissection and the study of cancer pathways.
A. Maitra (2001)
Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
A. Sandberg (1994)
10.1086/301749
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D. Ford (1998)
10.1093/AJCP/89.3.341
Flow cytometry in the diagnosis of acute leukemia.
J. Krause (1988)
10.1016/0968-0004(94)90130-9
Regulation of signal transduction and signal diversity by receptor oligomerization.
M. Lemmon (1994)
10.1586/14737159.1.2.191
Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies
B. Gleissner (2001)
10.1126/SCIENCE.1359641
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
A. Kallioniemi (1992)
10.1101/GR.9.8.681
Large-scale gene expression data analysis: a new challenge to computational biologists.
M. Zhang (1999)
10.1086/302418
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.
S. Teraoka (1999)
10.1016/0002-9610(86)90307-7
Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma.
S. Singletary (1986)
10.1016/S1383-5742(00)00058-2
DNA mismatch repair and cancer.
P. Peltomäki (2001)
10.1136/jcp.54.7.508
UK NEQAS for leucocyte immunophenotyping: the first 10 years
J. Reilly (2001)
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
D. Abeliovich (1997)
10.1007/s10434-000-0636-2
Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?
Nancy Klauber-Demore (2000)
10.1056/NEJM200107263450401
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
B. Modan (2001)
10.1038/sj.onc.1205315
Transcription factor fusions in acute leukemia: variations on a theme
J. Scandura (2002)
10.1038/sj.leu.2400893
Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients
RO Casasnovas (1998)
10.1046/J.1365-2257.1999.00214.X
Quality control of flow cytometric immunophenotyping of haematological malignancies.
J. Gratama (1999)
抗 Prostate-specific membrane antigen (PSMA) モノクロナル抗体の作成 : 抗腫瘍効果、他臓器でのPSMA発現の検討(第93回日本泌尿器科学会総会)
木下 義久 (2005)
10.1097/00125480-199601000-00001
Association of the Epstein‐Barr Virus with Hematolymphoid Neoplasia
L. Weiss (1996)
The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
J. Chen (1998)
10.1017/cbo9780511575792.027
Familial polyposis coli.
H. Bussey (1979)
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
M. Ocqueteau (1998)
10.1309/WMN8-VTR5-DUGF-X12L
Current status of HER2 testing: caught between a rock and a hard place.
S. Schnitt (2001)
10.1023/A:1008230331221
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients.
M. Sanchez-Cespedes (1998)
10.1126/SCIENCE.7604265
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.
F. Palombo (1995)
10.1016/0016-5085(95)90270-8
Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer.
R. F. Jacoby (1995)
10.1016/0531-5565(92)90068-B
The telomere hypothesis of cellular aging
C. Harley (1992)
10.1007/BF02054116
Frequency of hereditary nonpolyposis colorectal cancer
Jukka‐Pekka Mecklin (1995)
10.1097/00043426-200105000-00009
Molecular Confirmation of Ewing Sarcoma
R. Dagher (2001)
10.1007/978-3-642-60377-8_53
Immunophenotypic Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia
J. Ciudad (1997)
Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
A. McCann (1991)
10.1182/BLOOD.V82.6.1689.1689
Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
W. Miller (1993)
10.1159/000066224
Prediction of Response to Hormonal Treatment in Metastatic Breast Cancer
P. Schmid (2002)
10.1006/SCBI.2001.0395
From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
O. Monni (2001)
10.1128/MCB.17.8.4667
The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream.
R. Chan (1997)
10.1126/SCIENCE.8259518
Association of the APC gene product with beta-catenin.
B. Rubinfeld (1993)
10.1073/PNAS.97.17.9603
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
T. Kainu (2000)
10.7326/0003-4819-133-10-200011210-00009
Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles
Y. Su (2000)
10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G
Screening for high‐grade cervical intra‐epithelial neoplasia and cancer by testing for high‐risk HPV, routine cytology or colposcopy
A. Schneider (2000)
10.1111/j.1749-6632.1993.tb38783.x
CD45 Gating for Routine Flow Cytometric Analysis of Human Bone Marrow Specimens
G. T. Stelzer (1993)
10.1182/blood.v81.9.2399.2399
Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
K. Kita (1993)
10.1093/JNCI/95.2.142
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
G. Konecny (2003)
Genetics and biology of adult human male germ cell tumors.
R. Chaganti (2000)
10.1001/ARCHDERM.1988.01670030039019
Aberrant immunophenotypes in mycosis fungoides.
S. C. J. van der Putte (1988)
10.1016/S1525-1578(10)60694-0
Effectiveness of capillary electrophoresis using fluorescent-labeled primers in detecting T-cell receptor gamma gene rearrangements.
T. Greiner (2002)
Review Article Flow Cytometric Immunophenotyping of Non-Hodgkin's Lymphomas and Related Disorders
A. Tbakhi (1996)
10.1038/sj.bjc.6690144
Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
P. Jernvall (1999)
Chemical differeintiation along metaphase
T Caspersson (1968)
10.1016/0016-5085(87)90281-2
ras gene mutations in colorectal cancer
William E. Karnes (1987)
10.1002/1097-0142(19950915)76:6<985::AID-CNCR2820760611>3.0.CO;2-G
Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes
A. E. Chucrallah (1995)
10.1016/S0039-6109(05)70256-5
Pathologic analysis of the sentinel lymph node.
P. Treseler (2000)
10.1002/path.1024
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
M. Esteller (2002)
Zur Frage der Enstehung maligner Tumoren
T. Boveri (1914)
10.3892/IJO.18.4.793
Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Z. Gaci (2001)
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.
D. Ford (1995)
10.1093/NAR/GKF673
Identification of cellular mRNA targets for RNA-binding protein Sam68.
M. Itoh (2002)
10.1054/MODI.2000.16690
HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: comparison of results and correlation with survival.
S. Kakar (2000)
10.1038/NG0597-64
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
D. Liaw (1997)
10.1182/blood.v94.6.1998.418k01_1998_2006
ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells.
T. Fukao (1999)
10.1136/adc.66.8.971
Colorectal neoplasia in juvenile polyposis or juvenile polyps.
F. Giardiello (1991)
10.1126/SCIENCE.8128251
Mutation of a mutL homolog in hereditary colon cancer.
N. Papadopoulos (1994)
10.11501/3164365
Frequent p53 gene mutations in serrated adenomas of the colorectum
日山 亨 (1999)
AMR. Mutations associated with variant
CM McConville (1996)
10.1016/0165-4608(90)90042-9
Cytogenetic and molecular observations in human and experimental salivary gland tumors.
J. Sandros (1990)
10.1038/ng0902-89
ATM heterozygosity and cancer risk
P. Concannon (2002)
10.1097/00019606-199203000-00005
Detection of Rearrangements of the BCL2 Major Breakpoint Region in Follicular Lymphomas Correlation of Polymerase Chain Reaction Results With Southern Blot Analysis
M. Ladanyi (1992)
10.1038/321209A0
CpG-rich islands and the function of DNA methylation
A. Bird (1986)
10.1056/NEJMOA012158
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
T. Rebbeck (2002)
10.3322/canjclin.47.4.243
Adjuvant therapy for colon cancer
J. Macdonald (1999)
10.1126/SCIENCE.1566048
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
D. Sidransky (1992)
Syndecan-1 (CD 138) expression in human nonHodgkin lymphoma
A Sebestyen (1999)
Distal nephron renal tumors: microsatellite allelotype.
T. Polascik (1996)
10.1038/35076590
The emerging genetic and molecular basis of Fanconi anaemia
H. Joenje (2001)
10.1002/(SICI)1097-0142(20000425)90:2<75::AID-CNCR2>3.0.CO;2-W
Ancillary methods for the detection of recurrent urothelial neoplasia
J. Ross (2000)
10.1097/00000478-199710000-00014
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
Joseph A. DiGiuseppe (1997)
10.1200/JCO.1992.10.7.1044
Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.
S. Toikkanen (1992)
10.1093/nar/15.13.5323
High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12
G. Levinson (1987)
Les acides nucleiques du plasma sanguin chez l' homme
P. Mandel (1948)
10.1016/S0165-2478(00)00318-7
Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle.
H. Kamma (2001)
10.1038/NM0996-1035
Microsatellite alterations in serum DNA of head and neck cancer patients
H. Nawroz (1996)
10.1111/j.1365-2559.1995.tb00320.x
A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma
M. Ashton-Key (1995)
10.1136/gut.42.5.680
Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum
Y. Ajioka (1998)
10.1016/0016-5085(95)90071-3
Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
N. Yamashita (1995)
10.1016/S0950-3536(97)80003-0
BCR-ABL gene variants.
J. Melo (1997)
10.1006/MGME.1998.2693
A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia.
M. Telatar (1998)
10.1016/0090-1229(82)90134-9
Ataxia-Telangiectasia: a multiparameter analysis of eight families.
R. Gatti (1982)
The World Heath Organization (WHO
JW Vardiman (2002)
Cyclin Dl messenger RNA overexpression as a marker of mantle cell lymphoma
CJ de Boer (1995)
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
A. B. Sparks (1998)
10.1074/JBC.270.13.7111
Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3(*)
K. Carraway (1995)
10.1016/S0002-9610(01)00725-5
The learning curve and sentinel node biopsy.
L. Tafra (2001)
10.1200/JCO.1996.14.10.2702
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
C. Carlomagno (1996)
10.1126/SCIENCE.2649981
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
S. Baker (1989)
10.1097/00000478-198704000-00010
Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24-year-old man.
O. Bengoechea (1987)
10.1002/GCC.2870120115
Frequent Loss of Chromosome Arms 8p and 13q in Collecting Duct Carcinoma (CDC) of the Kidney
M. Schoenberg (1995)
10.1182/BLOOD.V91.3.735
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
F. Uckun (1998)
10.1016/S0304-3835(02)00010-1
Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy.
M. Tsuneizumi (2002)
10.1002/GEPI.1014
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study
A. Antoniou (2001)
10.1093/AJCP/111.3.379
Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification.
J. Siebert (1999)
10.1128/MCB.19.1.69
hnRNP H Is a Component of a Splicing Enhancer Complex That Activates a c-src Alternative Exon in Neuronal Cells
M. Y. Chou (1999)
10.1002/SSU.1039
Pathologic analysis of sentinel lymph nodes.
P. V. van Diest (2001)
Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Z. Guo (2001)
10.1586/14737159.2.2.91
Molecular diagnostics: impact upon cancer detection
S. Keesee (2002)
10.1073/PNAS.98.1.265
HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.
J. Young (2001)
ATM mutations in B-cell chronic lymphocytic leukemia.
F. Bullrich (1999)
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.
C. Purdie (1994)
10.1200/JCO.2002.12.033
Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
J. Kutok (2002)
10.1023/A:1008307821189
Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes.
A. Maraveyas (1999)
10.1089/10665270252833217
Inference from Clustering with Application to Gene-Expression Microarrays
E. Dougherty (2002)
Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium.
K. Woodford-Richens (2000)
10.1097/00000658-199509000-00016
Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy
A. Giuliano (1995)
10.1016/S0029-7844(01)01610-6
The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note.
A. Herbst (2001)
10.1073/pnas.091582298
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer
O. Monni (2001)
Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
T. Hashimoto (2000)
DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis.
J. Ross (1996)
10.1002/(SICI)1097-0320(19971015)30:5<236::AID-CYTO4>3.0.CO;2-F
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation.
M. Borowitz (1997)
10.1182/BLOOD.V87.11.4483.BLOODJOURNAL87114483
Mantle cell lymphoma-- an entity comes of age.
D. Weisenburger (1996)
10.1200/JCO.2001.19.16.3635
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
C. Balch (2001)
10.1056/NEJMOA012294
Detection of APC mutations in fecal DNA from patients with colorectal tumors.
G. Traverso (2002)
Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
W. Henle (1978)
Detection of BCR/ABL, MLLIAF4 and TELIAMLI hybrid genes and monitoring of minimal residual disease in pediatric patient with acute lymphoblastic leukemia
J Trka (1999)
10.1002/SSU.1048
Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
R. Ghossein (2001)
[Cancer of the penis: the value of systematic biopsy of the superficial inguinal lymph nodes in clinical N0 stage patients].
O. Bouchot (1993)
10.1182/blood.v94.6.1840
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
R. Damle (1999)
Repetitive human DNA: the shape of things to come, in: Chromosomes: Eukaryotic, Prokaryotic and Viral
CW Schmid (1989)
10.1038/NM0697-621
Detection of bladder cancer recurrence by microsatellite analysis of urine
G. Steiner (1997)
10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J
Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression.
V. Maino (1998)
10.1093/NAR/30.8.1725
Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.
P. Percipalle (2002)
10.1136/jmg.30.5.369
Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease.
S. Hodgson (1993)
10.1111/j.1651-2227.1981.tb05740.x
A NEW CHROMOSOMAL INSTABILITY DISORDER: THE NIJMEGEN BREAKAGE SYNDROME
C. Weemaes (1981)
10.1007/BF00210809
Unusual features in the inheritance of ataxia telangiectasia
C. G. Woods (2004)
10.1016/S0037-1963(00)90018-0
Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia.
A. Ferrando (2000)
10.1016/0016-5085(95)90201-5
K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas.
W. Giaretti (1995)
10.1078/0344-0338-00145
Value of morphological criteria in diagnosing cervical HPV lesions confirmed by in situ hybridization and hybrid capture assay.
C. Roteli-Martins (2001)
Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.
A. Yanagisawa (1993)
10.1056/NEJM200104193441603
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T. Watanabe (2001)
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D. Easton (1995)
Aberrant T-cell immunophenotype in viral infections: a limitation in the immunophenotypic diagnosis ofT -celllymphoproliferative disorders
CA Hanson (1998)
Unmutated fg Vh genes
TJ Hamblin (1999)
10.1038/ng958
Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer
K. Spring (2002)
A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer.
V. Pawlowski (2000)
10.1002/(SICI)1097-0142(19980501)82:9<1704::AID-CNCR17>3.0.CO;2-8
Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran
R. Offodile (1998)
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
K. Flatmark (2002)
10.1023/A:1010631915831
Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer
J. Zhou (2004)
Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
W. Köstler (2000)
10.1023/A:1006260319913
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
P. Anker (2004)
10.1136/mp.53.6.289
Microarray techniques in pathology: tool or toy?
A. Snijders (2000)
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
M. Tockman (1997)
10.1038/NG0596-126
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
S. Neuhausen (1996)
Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance.
S. Kornblau (1995)
10.1074/jbc.M004692200
Heterogeneous Ribonucleoprotein A1 Is Part of an Exon-specific Splice-silencing Complex Controlled by Oncogenic Signaling Pathways*
N. Matter (2000)
10.1073/PNAS.83.9.2984
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.
P. Pelicci (1986)
10.1172/JCI107165
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases.
D. Koffler (1973)
Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level.
W. Samowitz (2001)
10.1126/SCIENCE.1257746
High resolution of human chromosomes.
J. Yunis (1976)
10.1126/SCIENCE.8091231
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R. Wooster (1994)
10.1097/00129039-200203000-00001
Tissue Microarrays: A Powerful Tool for High-Throughput Analysis of Clinical Specimens: A Review of the Method With Validation Data
M. Skacel (2002)
10.1111/J.1349-7006.1994.TB02075.X
Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas
S. Yamagata (1994)
10.1007/s004180050181
Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies
H. Zitzelsberger (1997)
10.1182/BLOOD.V93.11.3931.411A30_3931_3939
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
M. Czuczman (1999)
Allelotype of head and neck squamous cell carcinoma.
H. Nawroz (1994)
10.1046/j.1365-2141.1997.72653.x
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage
A. Rawstron (1997)
10.1097/00005792-199311000-00003
Bloom Syndrome: A Mendelian Prototype of Somatic Mutational Disease
J. German (1993)
10.1182/BLOOD.V92.3.795.415K01_795_801
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.
M. C. Putti (1998)
10.1038/sj.onc.1202692
Mutations in the RAD54 recombination gene in primary cancers
M. Matsuda (1999)
10.1038/sj.onc.1205086
A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation
L. Ford (2002)
Cowden disease. Report of a family and review.
M. Longy (1996)
Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study.
D. Persons (2000)
10.1002/(SICI)1097-0320(19981001)33:2<244::AID-CYTO20>3.0.CO;2-T
Novel flow cytometry compensation standards: internally stained fluorescent microspheres with matched emission spectra and long-term stability.
Y. Zhang (1998)
10.1016/S0165-4608(99)00075-8
Cytogenetic analysis of upper urinary tract transitional cell carcinomas.
I. Fadl-Elmula (1999)
10.1182/BLOOD-2002-04-1199
The World Health Organization (WHO) classification of the myeloid neoplasms.
J. Vardiman (2002)
Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.
Y. Akiyama (1997)
10.1073/PNAS.79.24.7824
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
R. Dalla‐Favera (1982)
10.1002/path.893
Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies
L. Bubendorf (2001)
10.1182/BLOOD.V100.1.59
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.
S. Schnittger (2002)
10.1002/SSU.2980030304
Alterations in DNA methylation in human colon neoplasia.
A. Feinberg (1987)
10.1016/0169-5002(95)00514-5
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium.
J. Zhou (1996)
10.2307/1535741
THE CHROMOSOMES IN HEREDITY
W. Sutton (1903)
10.1056/NEJM198809013190901
Genetic alterations during colorectal-tumor development.
B. Vogelstein (1988)
10.1007/BF02899261
Amplifiedbcl-2/JH rearrangements in reactive lymphadenopathy
K. Ohshima (1993)
10.1016/S0014-5793(00)01773-7
Functional genomics by mass spectrometry
J. Andersen (2000)
Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
E. De Leon (1998)
10.1097/00006254-199906000-00017
EFFICACY OF BILATERAL PROPHYLACTIC MASTECTOMY IN WOMEN WITH A FAMILY HISTORY OF BREAST CANCER
L. Hartmann (1999)
10.1006/EXCR.1995.1152
Alteration of DNA and RNA binding activity of human telomere binding proteins occurs during cellular senescence.
K. Hubbard (1995)
10.1016/S0093-7754(01)90125-3
Role of adjuvant endocrine therapy in early-stage breast cancer.
H. Muss (2001)
10.1016/S0002-9440(10)62549-7
Diverse tumorigenic pathways in ovarian serous carcinoma.
G. Singer (2002)
10.1007/978-3-642-59696-4_3
Promoter-region hypermethylation and gene silencing in human cancer.
J. Herman (2000)
10.1016/S0165-4608(97)00344-0
Translocation (12;14) in lipoma: a case report and review of the literature.
S. Y. Dong (1998)
10.1038/368569A0
Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair
M. Strand (1994)
10.1002/j.1460-2075.1996.tb00356.x
ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
D. Karunagaran (1996)
10.1016/S0959-8049(99)00253-1
Molecular pathology and future developments.
J. Going (1999)
10.1016/S0304-3835(98)00168-2
Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity.
J. Goussard (1998)
10.1016/S0016-5085(08)80311-3
One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: Detection of missed micrometastases
T. F. Wood (2001)
A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
D. P. Huang (1994)
10.1046/j.1365-2141.1996.d01-1728.x
Rearrangement of the BCL6 gene in B‐cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement
M. Muramatsu (1996)
A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.
M. Sasaki (1973)
10.1001/JAMA.286.18.2251
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
M. King (2001)
10.1038/35106009
Assessing TP53 status in human tumours to evaluate clinical outcome
T. Soussi (2001)
10.1056/NEJM199407283310401
Allelic loss of chromosome 18q and prognosis in colorectal cancer.
J. Jen (1994)
10.1093/emboj/16.7.1647
ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
D. Graus-Porta (1997)
Expression of heterogeneous nuclear ribonucleoprotein
J Zhou (1998)
10.1016/0165-4608(93)90070-3
Endometrial polyp: another benign tumor characterized by 12q13-q15 changes.
R. Vanni (1993)
10.1016/S0022-5347(05)65842-9
Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer.
A. Sherif (2001)
10.1007/BF01296086
Clinicopathological features and endoscopic diagnosis of superficial early adenocarcinomas of the large intestine
H. Iishi (2005)
10.1101/GAD.13.5.593
Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene.
C. Chen (1999)
10.1016/S0016-5085(98)70424-X
Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.
J. Carethers (1998)
Immunophenotypic analysis of haematological disorders
WN Erber (1996)
10.1200/JCO.1998.16.8.2659
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
M. Pegram (1998)
Comparative genomic hybridization: an overview.
J. Houldsworth (1994)
10.1111/j.1365-2141.1994.tb04911.x
Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications
F. Lauria (1994)
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
J. Silva (1999)
10.1002/1096-9896(200103)193:3<283::AID-PATH799>3.0.CO;2-9
Serrated route to colorectal cancer: back street or super highway?
J. Jass (2001)
10.1016/S0140-6736(97)10295-1
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
E. Coustan-Smith (1998)
DNA ligase IV mutations
M O'Driscoll (2001)
10.1073/PNAS.93.20.10595
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
O. Iliopoulos (1996)
10.1073/PNAS.93.20.10589
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.
J. Gnarra (1996)
10.1148/RADIOLOGY.207.1.66
TNM Classification of Malignant Tumors. 5th ed
R. Szucs (1998)
10.1016/S0165-4608(98)00205-2
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
M. Aubele (1999)
10.1146/ANNUREV.GENET.31.1.635
Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart.
Y. Shiloh (1997)
10.1182/BLOOD.V81.11.3083.BLOODJOURNAL81113083
Expression of unusual immunophenotype combinations in acute myelogenous leukemia.
C. Reading (1993)
10.1016/S0145-2126(99)00150-2
Lineage specificity of CBFA2 fusion transcripts.
E. Dann (2000)
10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S
Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
B. Shapiro (1983)
10.1016/S0165-4608(98)00153-8
Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis.
H. Khalidi (1999)
The concordance between the clinical trials assay (CTA) and fluorescence in situ hybridization (FISH) in the Herceptin pivotal trials
RD Mass (2003)
10.1159/000226740
Neoplastic characteristics of the DNA found in the plasma of cancer patients.
M. Stroun (1989)
CpG island
A0-0 Chan (2002)
10.1073/PNAS.85.8.2748
Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.
A. Neri (1988)
10.1007/s004390100459
A new multicolor-FISH approach for the characterization of marker chromosomes: centromere-specific multicolor-FISH (cenM-FISH)
A. Nietzel (2001)
10.1002/ijc.1354
Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears
S. H. Rha (2001)
Review of mammalian DNA repair and translational implications.
W. K. Hansen (2000)
10.1038/sj.leu.2402033
Transcription factors and translocations in lymphoid and myeloid leukemia
HN Crans (2001)
10.1007/978-3-642-59696-4_7
CpG-island methylation in aging and cancer.
J. Issa (2000)
10.1093/JNCI/91.4.332
Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.
S. Ahrendt (1999)
Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
E. Di Bona (2002)
10.1002/GCC.2870040209
t(11;18)(q21;q21) is a recurrent chromosome abnormality in small lymphocytic lymphoma
Constance A. Griffin (1992)
Mantle cell lymphoma: biology and diagnosis, in Hematology
ES Jaffe (1999)
10.1002/IJC.2910130509
Attempts to detect virus‐specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus
H. Hausen (1974)
10.1016/S0002-9440(10)64625-1
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
A. Maitra (2000)
10.1093/AJCP/110.5.582
Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma.
J. Tworek (1998)
Detection of the chromosomal translocation
R Rimokh (1994)
10.1053/HUPA.2002.30377
Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps.
F. Fogt (2002)
Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
S. Dong (2002)
10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I
An approach for the treatment of penile carcinoma
R. Cabanas (1977)
10.1101/SQB.1993.058.01.084
Studies of metaphase and interphase chromosomes using fluorescence in situ hybridization.
B. Trask (1993)
10.1016/0304-3835(93)90062-E
Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
S. Marsigliante (1993)
10.1385/CRIAI:20:1:87
The pathogenesis of ataxia-telangiectasia
R. Gatti (2001)
10.1182/BLOOD.V98.6.1746
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.
J. S. San Miguel (2001)
10.1016/S1535-6108(02)00039-9
Smart drugs: tyrosine kinase inhibitors in cancer therapy.
L. Shawver (2002)
The t(l2;21) of acute lymphoblastic leukemia results in a tel-AMLJ gene fusion
SP Romana (1995)
10.1128/MCB.19.7.4572
Assembly of the α-Globin mRNA Stability Complex Reflects Binary Interaction between the Pyrimidine-Rich 3′ Untranslated Region Determinant and Poly(C) Binding Protein αCP
A. Chkheidze (1999)
10.1086/323703
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.
X. Zhou (2001)
10.1097/00008390-200204000-00007
Detection of nodal micrometastases using immunohistochemistry and PCR in melanoma of the arm and trunk
S. Boi (2002)
10.1046/j.1365-2141.1998.00603.x
Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse‐transcriptase polymerase chain reaction in B‐cell non‐Hodgkin's lymphomas
N. Kawamata (1998)
10.1182/BLOOD.V87.8.3520.BLOODJOURNAL8783520
Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia.
E. Matutes (1996)
10.1053/EJSO.2001.1252
Sentinel lymph node biopsy in breast cancer--is lymphoscintigraphy really necessary?
S. Upponi (2002)
10.1038/ng1060
A molecular signature of metastasis in primary solid tumors
S. Ramaswamy (2003)
Genetic heterogeneity in familial juvenile polyposis.
S. C. Huang (2000)
10.1309/4NTU-N6K4-F8JF-EWRX
HER2/neu amplification in breast cancer: stratification by tumor type and grade.
E. Hoff (2002)
DNA microarrays in lymphoid malignancies.
A. Rosenwald (2003)
10.1043/0003-9985(2000)124<0958:COAPCX>2.0.CO;2
College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation
M. Hammond (2000)
10.1038/sj.leu.2401773
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML
S. Schnittger (2000)
10.1056/NEJMOA012015
Primary chemoprevention of familial adenomatous polyposis with sulindac.
F. Giardiello (2002)
benign melanocytic nevi
A Parmiter (1988)
10.1126/SCIENCE.8259519
Association of the APC tumor suppressor protein with catenins.
L. Su (1993)
The release of DNA
GR Hughes (1971)
High reliability and sensitivity of the BCRJABLI D-FISH test for the detection
F Pelz (2002)
Applications ofproteomics in oncology
Ross (2000)
10.1093/JNCI/90.8.606
Multiple primary cancers in families with Li-Fraumeni syndrome.
M. Hisada (1998)
10.1182/BLOOD.V90.4.1643.1643_1643_1648
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
M. Baer (1997)
10.1086/340258
Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot.
J. Howe (2002)
10.1053/GAST.2000.17952
p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation.
C. Y. Dai (2000)
10.1038/NG1096-188
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
C. Oddoux (1996)
10.1016/S0022-5347(01)66671-0
Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.
C. Pettaway (1995)
10.18356/7650330d-en
DNA Repair and Mutagenesis
E. Friedberg (2006)
10.1046/J.1365-2168.2002.02294.X
Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes
M. Noguchi (2002)
10.1093/AJCP/109.5.508
Hepatitis C virus and non-Hodgkin's lymphoma.
R. Lai (1998)
10.1016/S0002-9440(10)63062-3
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
J. Young (2001)
10.1126/SCIENCE.7761852
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.
S. Markowitz (1995)
10.1074/jbc.272.51.31941
RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 *
A. K. Wong (1997)
10.1002/1097-0320(20000801)40:4<280::AID-CYTO4>3.0.CO;2-7
Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy.
P. Smith (2000)
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
R. Elledge (1998)
10.1586/14737159.1.1.1
Molecular diagnostics: a powerful new component of the healthcare value chain
G. Poste (2001)
10.1097/00019606-199912000-00001
Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas.
R. Ghossein (1999)
10.1046/j.1365-2141.2000.01801.x
THE MANAGEMENT OF PATIENTS WITH LEUKAEMIA: THE ROLE OF CYTOGENETICS IN THIS MOLECULAR ERA
C. Harrison (2000)
10.1016/S0889-8561(05)70141-7
ATAXIA-TELANGIECTASIA : A Primary Immunodeficiency Revisited
J. R. Regueiro (2000)
10.1200/JCO.1998.16.3.1103
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
O. Eton (1998)
Flow cytometry: its applications in hematology.
A. Orfao (1995)
10.1053/GAST.1996.V110.PM8608884
Serrated adenomatous polyposis in humans.
E. Torlakovic (1996)
10.1016/S0272-2712(18)30072-6
Morphology and classification of acute myeloid leukemias.
J. Krause (2000)
10.1080/003130299104774
The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders.
M. Ward (1999)
10.1038/35044000
In search of the tumour-suppressor functions of BRCA1 and BRCA2
R. Scully (2000)
10.1046/j.1468-3083.2002.00360.x
Molecular analyses of sentinel lymph nodes: an open question
S. Bonin (2002)
Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
J. Califano (1999)
10.1074/jbc.274.2.1066
G4 DNA Binding by LR1 and Its Subunits, Nucleolin and hnRNP D, A Role for G-G pairing in Immunoglobulin Switch Recombination*
L. Dempsey (1999)
Blastic mantle cell leukemia: an unusual variant of blastic mantle cell lymphoma
DS Viswanatha (2000)
10.1093/JNCI/94.18.1365
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
M. Brose (2002)
10.1038/modpathol.3880154
HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization Approach
Ren L Ridolfi (2000)
10.1016/S0016-5085(03)81193-9
Frequent CpG island methylation in serrated adenomas of the colorectum.
Seun-Ja Park (2003)
Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay.
Y. Huo (1994)
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
S. Baker (1990)
10.1053/GAST.2001.21170
APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.
H. Stern (2001)
10.1126/SCIENCE.2999974
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.
L. Coussens (1985)
10.1038/363558A0
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
Y. Ionov (1993)
10.1016/S0165-4608(96)00252-X
Clinical significance of cytogenetic findings in solid tumors.
F. Mitelman (1997)
Genetic testing and counseling in familial adenomatous polyposis.
G. Petersen (1996)
Loss of heterozygosity for loci
D Millikin (1991)
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
J. Codony-Servat (1999)
10.1159/000020054
The Sentinel Lymph Node Concept in Prostate Cancer – First Results of Gamma Probe-Guided Sentinel Lymph Node Identification
F. Wawroschek (1999)
PRAD-11 cyclin Dl gene overexpression in chronic lymphopro1iferative disorders: a highly specific marker of mantle cell lymphoma
F Bosch (1994)
10.1097/00019606-200103000-00005
PCR Techniques for Clonality Assays
S. Diaz-Cano (2001)
10.1182/blood.v70.6.1816.1816
Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region.
E. Lipford (1987)
10.1038/labinvest.3780256
Cryptic Translocation Identification in Human and Mouse Using Several Telomeric Multiplex FISH (TM-FISH) Strategies
O. Henegariu (2001)
10.1200/JCO.2002.20.7.1932
DNA microarrays in clinical oncology.
S. Ramaswamy (2002)
10.1073/pnas.231326898
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
I. Sæterdal (2001)
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
Y. Lo (1999)
10.1006/GYNO.1999.5660
Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva.
K. Terada (2000)
10.1002/1097-0142(19950515)75:10<2474::AID-CNCR2820751013>3.0.CO;2-Y
Acute agranular CD4‐positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents
J. Brody (1995)
10.1016/0014-4827(88)90265-0
A simple technique for quantitation of low levels of DNA damage in individual cells.
N. Singh (1988)
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
M. Miyaki (1994)
10.1056/NEJM198904203201605
bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma.
J. Yunis (1989)
10.1016/S0169-5002(03)00033-3
Dissecting the genetic alterations involved in lung carcinogenesis.
M. Sánchez-Céspedes (2003)
10.1038/NG0897-333
Germline mutations in PTEN are present in Bannayan-Zonana syndrome
D. Marsh (1997)
10.1097/00043764-198910000-00001
Genetic Alterations During Colorectal-Tumor Development
E. Gresch (1989)
10.1097/00005072-197911000-00007
ATAXIA‐TELANGIECTASIA WITH A 32 YEAR SURVIVAL A CLINICOPATHOLOGICAL REPORT
G. Amromin (1979)
10.1016/S0065-230X(08)60702-2
Alterations in DNA methylation: a fundamental aspect of neoplasia.
S. Baylin (1998)
10.1182/BLOOD.V93.11.3601.411A47_3601_3609
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.
J. Dierlamm (1999)
10.1006/GYNO.1998.5035
Combined use of intraoperative lymphatic mapping and lymphoscintigraphy in the management of squamous cell cancer of the vulva.
K. Terada (1998)
10.1093/CLINCHEM/46.8.1252
Multifaceted approach to the diagnosis and classification of acute leukemias.
R. Mckenna (2000)
10.1002/j.1460-2075.1996.tb00550.x
p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction.
H. W. Stürzbecher (1996)
10.1093/JNCI/93.17.1307
Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.
N. Hawkins (2001)
10.1002/1097-0215(20010920)95:5<307::AID-IJC0153>3.0.CO;2-Q
Reverse transcription‐polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes
M. Manzotti (2001)
10.1155/2001/746827
Flow Cytometric DNA Analysis Using Cytokeratin Labeling for Identification of Tumor Cells in Carcinomas of the Breast and the Female Genital Tract
R. Kimmig (2001)
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
K. Murphy (2002)
10.1128/MCB.20.22.8303-8318.2000
Selection of Alternative 5′ Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1
I. Eperon (2000)
10.1200/JCO.1999.17.1.434
Increased HER2 with U.S. Food and Drug Administration-approved antibody.
P. Roche (1999)
10.1101/GAD.12.19.2984
Tumor surveillance via the ARF-p53 pathway.
C. Sherr (1998)
10.1006/GYNO.2001.6289
Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
V. W. Liu (2001)
Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
R. Kikuchi-Yanoshita (1992)
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
T. Järvinen (1999)
10.1182/BLOOD.V98.1.165
Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations.
A. Langerak (2001)
10.1002/(SICI)1098-2264(199912)26:4<346::AID-GCC9>3.0.CO;2-D
Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix
A. Kersemaekers (1999)
The chromosomes in human cancer and leukemia
A. Sandberg (1990)
10.1001/JAMA.1997.03540350065035
Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer
W. Burke (1997)
10.1043/0003-9985(2002)126<0775:COAOMR>2.0.CO;2
Coming of age of melanogenesis-related proteins.
A. Słomiński (2002)
10.1038/nrc950
The retinoblastoma tumour suppressor in development and cancer
M. Classon (2002)
10.1016/S0037-1963(01)90045-9
Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
M. Stetler-Stevenson (2001)
10.1016/S1525-1578(10)60636-8
Molecular diagnostic approach to non-Hodgkin's lymphoma.
D. Arber (2000)
Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
A. Hoque (2002)
Cancer of the microsatellite mutator phenotype.
M. Perucho (1996)
10.1126/SCIENCE.8235596
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.
B. H. Ye (1993)
10.1002/IJC.2910530307
Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma
K. Ookawa (1993)
10.1182/BLOOD.V65.4.974.BLOODJOURNAL654974
The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia.
R. Schwarting (1985)
10.1002/IJC.2910610327
The von Hippel‐Lindau (VHL) disease tumor‐suppressor gene is not mutated in nasopharyngeal carcinomas
Y. Sun (1995)
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.
J. Rueschoff (1997)
10.1016/0092-8674(92)90243-6
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Laura R. Livingstone (1992)
primary breast cancers
G Ragnarsson (1999)
p53 expression in colorectal adenomas.
L. Kaklamanis (1993)
The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing.
H. Battifora (1986)
10.1023/A:1008202303666
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas.
I. A. Auer (1997)
10.1111/j.1749-6632.2001.tb03859.x
A Framework for the Molecular Classification of Circulating Tumor Markers
P. Johnson (2001)
10.1182/BLOOD.V79.10.2527.BLOODJOURNAL79102527
Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma.
C. Bastard (1992)
10.1038/sj.leu.2401382
A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies
T. Niehues (1999)
10.1016/S0016-5085(82)80398-3
Familial juvenile polyposis coli. A clinical and pathologic study of a large kindred.
H. Grotsky (1982)
10.1016/S0046-8177(00)80216-6
Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.
C. S. Fan (2000)
10.1097/00000478-199006000-00003
Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia
T. Longacre (1990)
10.1016/S0140-6736(78)90487-7
ÆTIOLOGY OF ADENOMA—CARCINOMA SEQUENCE IN LARGE BOWEL
Mary J. Hill (1978)
10.1111/j.1365-2141.1994.tb04983.x
Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies
W. Erber (1994)
10.1056/NEJM199705153362001
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J. Struewing (1997)
10.1097/00129039-200009000-00010
Fixation and Epitope Retrieval in Diagnostic Immunohistochemistry: A Concise Review with Practical Considerations
R. T. Miller (2000)
Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.
A. Whittemore (1997)
Genetic changes in epithelial solid neoplasia.
E. Rodríguez (1994)
10.1081/CNV-120000371
Mismatch Repair and the Hereditary Non-polyposis Colorectal Cancer Syndrome (HNPCC)
A. Müller (2002)
Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
H. Yamamoto (1997)
10.1136/ijgc-00009577-200303001-00383
SENTINEL NODE DETECTION IN CERVICAL CANCER
L. Bocciolone (2003)
10.1038/NG1095-198
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
J. Struewing (1995)
10.1093/AJCP/105.4.458
Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia.
W. G. Finn (1996)
Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
M. Wilhelm (1995)
10.1093/OXFORDJOURNALS.AJE.A116271
The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics.
L. Strong (1992)
10.1111/J.1749-6632.1993.TB38762.X
Assessment of Interlaboratory Variability of Immunophenotyping
H. A. Homburger (1993)
Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
A. Macedo (1995)
10.1016/0888-7543(95)80035-K
Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1.
T. Kozu (1995)
10.1093/emboj/cdf625
Decrease in hnRNP A/B expression during erythropoiesis mediates a pre‐mRNA splicing switch
V. Hou (2002)
Technical Advance Detection of Immunoglobulin k Light Chain Rearrangements by Polymerase Chain Reaction An Improved Method for Detecting Clonal B-Cell Lymphoproliferative Disorders
Jerry Z. Gong (1999)
10.1007/978-3-642-59537-0_4
Detection of micrometastasis through tissue-specific gene expression: its promise and problems.
R. Jung (2001)
Germ1ine mutations of the gene encoding bone morphogenetic protein receptor 1A injuveni1e polyposis
JR Howe (2001)
Can man CE, eta
Lim D-S (1998)
10.1002/1097-0142(19900415)65:8<1794::AID-CNCR2820650821>3.0.CO;2-Y
correlation between histologic grade of malignancy and copy number of c‐erbb‐2 gene in breast carcinoma. A retrospective analysis of 176 cases
H. Tsuda (1990)
Smith's Recognizable Patterns of Human Malformation
K. Jones (1996)
10.1002/(SICI)1097-0215(19980821)79:4<411::AID-IJC17>3.0.CO;2-7
Allelic loss and prognosis in carcinoma of the uterine cervix
Anne‐Marie F. Kersemaekers (1998)
10.1006/BCMD.2000.0342
Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
M. Lima (2000)
10.1016/S0016-5085(97)70032-5
Microsatellite instability in colorectal adenomas.
W. Samowitz (1997)
10.1083/JCB.109.6.2575
A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts
S. Piñol-Roma (1989)
10.1200/JCO.2001.19.10.2714
Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message.
R. Tubbs (2001)
10.1126/SCIENCE.280.5366.1077
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.
D. Wang (1998)
10.1002/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y
FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q
Y. Jin (1998)
Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy.
P. Nagy (1999)
10.1182/BLOOD.V96.4.1297.H8001297_1297_1308
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Mole
D. Grimwade (2000)
10.1016/S1071-9091(03)00026-3
Ataxia-telangiectasia: diagnosis and treatment.
S. Perlman (2003)
10.1016/S0022-1759(01)00389-1
Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation.
U. Oelschlaegel (2001)
10.1002/jcp.10147
Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence
D. Zhu (2002)
10.1046/j.1365-2133.2001.04334.x
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription–polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness
H. Blaheta (2001)
10.1515/CCLM.2000.120
Quantitative PCR.
R. Jung (2000)
10.1067/MSY.2002.119579
Detection of micrometastasis in the sentinel lymph nodes in breast cancer.
Mayumi Ishida (2002)
10.1016/S0002-9440(10)63075-1
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
J. Torhorst (2001)
10.1038/sj.leu.2401177
Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study
M. Borowitz (1998)
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
J. Silva (2002)
10.1086/321296
Global analysis of ATM polymorphism reveals significant functional constraint.
Y. Thorstenson (2001)
10.1016/S0022-1759(01)00305-2
Use of serial analysis of gene expression (SAGE) technology.
M. Yamamoto (2001)
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
P. van der Riet (1994)
Surface marker abnormalities in myelodysplastic syndromes.
M. T. Elghetany (1998)
10.1053/GAST.1996.V111.PM8690195
Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
M. Konishi (1996)
10.1038/NG0594-85
Mutations of the VHL tumour suppressor gene in renal carcinoma
J. Gnarra (1994)
10.1002/1097-0142(19890901)64:5<1138::AID-CNCR2820640529>3.0.CO;2-A
Early colorectal carcinoma with special reference to its development de novo
T. Shimoda (1989)
10.1002/(SICI)1098-2264(199902)24:2<160::AID-GCC10>3.0.CO;2-C
TP53 gene mutations in plasma DNA of cancer patients
J. Silva (1999)
Harvesting, slidemaking, and chromosome elongation
HJ Lawce (1991)
10.1016/S1535-6108(02)00018-1
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
A. Ferrando (2002)
10.1111/j.1600-065X.2000.imr017514.x
E2A proteins: essential regulators at multiple stages of B‐cell development
B. Kee (2000)
10.1007/s00268-001-0226-x
Sentinel Node Concept in Gastric Carcinoma
T. Ichikura (2001)
10.1038/35101008
Cancer gene therapy: fringe or cutting edge?
F. McCormick (2001)
10.1016/0092-8674(93)90538-2
Alleles of the APC gene: An attenuated form of familial polyposis
L. Spirio (1993)
Ataxia-telangiectasia locus: analysis of 184 kb DNA provides evidence for mosaic genomic structure and complex transcriptional regulation of the ATM gene
M Platzer (1997)
10.1128/JVI.75.18.8487-8497.2001
RNA Splicing at Human Immunodeficiency Virus Type 1 3′ Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element
P. S. Bilodeau (2001)
10.1093/CLINCHEM/45.10.1708
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
A. Orfao (1999)
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
C. Goessl (2000)
B-cell chronic lymphocytic leukemia: present status and future directions (review)
G Dighiero (1991)
10.1038/368867A0
An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis
S. Taylor (1994)
10.1074/jbc.M200748200
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks*
Q. Zhong (2002)
10.1016/S0093-7754(02)90013-8
Hematologic malignancies: new developments and future treatments.
B. Cheson (2002)
10.1074/JBC.M103160200
Residual Ataxia Telangiectasia Mutated Protein Function in Cells from Ataxia Telangiectasia Patients, with 5762ins137 and 7271T→G Mutations, Showing a Less Severe Phenotype*
G. Stewart (2001)
Radioimmunochemical studies on nucleoside-specific antibodies using iodinated DNA.
B. Rosenberg (1972)
10.1086/301706
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
T. Stankovic (1998)
10.1093/NAR/29.11.2268
hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro.
S. Fiset (2001)
This was the first chromosomal abnormality to be recognized as a recurring aberration in a human cancer
Nowell (1960)
10.1007/BF02966514
Correlation of allelic losses and clinicopathological factors in primary breast cancers
M. Emi (2002)
Sentinel lymph node mapping in colorectal cancera review
S SO. Saha (2000)
10.1182/BLOOD.V88.9.3626.BLOODJOURNAL8893626
Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.
M. Hanson (1996)
10.1126/SCIENCE.8484122
Microsatellite instability in cancer of the proximal colon.
S. Thibodeau (1993)
The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer.
R. Nejat (1998)
Mitelman Database of Chromosomal Abberations in Cancer.Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman
F Mitelman (2003)
10.1093/JNCI/87.10.742
Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix.
A. Mitra (1995)
10.1002/(SICI)1098-2264(199610)17:2<118::AID-GCC7>3.0.CO;2-8
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma
L. F. Hu (1996)
10.1038/43932
Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination
R. Johnson (1999)
10.1016/S0304-419X(98)00017-1
The p16INK4a/CDKN2A tumor suppressor and its relatives.
M. Ruas (1998)
Association of BRCAI with the hRad50-hMrell -p95 complex and the DNA damage
Q Zhong (1999)
10.1111/j.1365-2141.1995.tb05253.x
Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission
K. Tobal (1995)
10.1136/gut.40.5.660
High frequency of K-ras mutations in human colorectal hyperplastic polyps.
K. Otori (1997)
10.1634/stemcells.20-3-215
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies
A. Countouriotis (2002)
10.1073/PNAS.95.15.8698
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.
M. Veigl (1998)
10.1053/GAST.2000.18161
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
Akseli Hemminki (2000)
Molecular determinants of dysplasia in colorectal lesions.
J. Jen (1994)
10.1006/MGME.1999.2942
Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.
R. Gatti (1999)
10.1007/BF00665980
The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases
N. Quénel (2004)
10.1016/0277-5379(91)91516-l
Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
C. Geisler (1991)
10.1016/S0022-1759(01)00550-6
Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry.
W. Corver (2002)
10.1074/JBC.M105391200
The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression*
P. Pioli (2001)
10.1038/sj.onc.1204639
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
P. Ayton (2001)
No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas.
V. Launonen (2000)
10.1182/BLOOD-2002-12-3639
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
A. Guarini (2003)
10.1038/NBT0198-91
Methods for extracting and amplifying genomic DNA isolated from frozen serum
S. C. Dixon (1998)
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
X. Chen (1999)
10.1083/JCB.149.2.307
The Mkk3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation
W. van der Houven van Oordt (2000)
10.3892/IJO.16.6.1165
Outcome of pancreatic cancer patients based on genetic lymph node staging.
T. Yamada (2000)
10.1182/BLOOD.V92.2.596.414K05_596_599
The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).
M. Béné (1998)
10.1016/S0304-419X(97)00032-2
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.
E. Tzahar (1998)
10.1002/(SICI)1097-0320(19981001)33:2<106::AID-CYTO4>3.0.CO;2-H
Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry.
A. Schwartz (1998)
A rapid sensitive radioassay for serum native and denatured DNA.
Richard A. V. Cox (1977)
[Sentinel lymph node diagnosis in prostatic carcinoma: I: Method and clinical evaluation].
H. Vogt (2002)
10.1200/JCO.2001.19.18.3808
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.
M. Ellis (2001)
10.1182/BLOOD.V90.2.571.571_571_577
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
A. Borkhardt (1997)
10.1097/01.GIM.0000105741.57923.08
A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia
S. Goorha (2004)
10.1046/j.1365-2141.2000.02153.x
Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods
E. Forestier (2000)
10.1007/BF00191223
Efficient nonhomologous and homologous recombination in scid cells
B. Bühler (2004)
Recent advances in the molecular genetics of malignant melanoma.
F. Haluska (1995)
10.1007/978-1-4615-5195-9_6
S-phase fraction and breast cancer — a decade of experience
C. Wenger (1998)
10.1002/GCC.2870120208
A genetic model of melanoma tumorigenesis based on allelic losses
G. Walker (1995)
Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.
T. O’Leary (1999)
Distinct types of diffuse large B-celllymphoma identified by gene expression
AA Alizadeh (2000)
Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
L. Weiss (1985)
10.1007/s004230000143
Principles of sentinel lymph node identification: background and clinical implications
A. Cochran (2000)
Molecular genetics and the diagnosis of lymphoma.
J. Cossman (1988)
10.1038/NM0795-635
To metastasize or not? Selection of CD44 splice sites
D. L. Cooper (1995)
10.1517/14622416.1.4.375
Gene expression analysis as an aid to the identification of drug targets.
E. Zanders (2000)
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(l6) (pl3q22)exhibits a specific immunophenotype with C02 expression
HJ Adriaansen (1993)
A clincopatholgic study
S Tada (1994)
10.1002/ajmg.a.20570
Five haplotypes account for fifty‐five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: Seven new mutations
G. Coutinho (2004)
10.21236/ada463007
Serum Genetic Markers as Surrogates of Prostate Cancer Progression
D. Hoon (2006)
10.1002/(SICI)1097-0215(19961104)68:3<291::AID-IJC4>3.0.CO;2-X
Genomic instability in colorectal cancers in Turkey
T. Yagci (1996)
Expression of heterogeneous nuclear ribonucleopro
LM Montuenga (1998)
10.1016/0165-4608(90)90024-5
Cytogenetics of human brain tumors.
S. Bigner (1990)
10.1016/S0968-6053(00)80051-4
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
N. Harris (1994)
10.1002/(SICI)1097-0142(19990915)86:6<990::AID-CNCR14>3.0.CO;2-D
Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma
K. Dowlatshahi (1999)
10.1309/AAYH-1FK8-38PL-Q6DT
Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
C. Echeverri (2002)
Genetic analysis of benign, low-grade, and high-grade ovarian tumors.
H. Iwabuchi (1995)
10.1038/sj.leu.2401711
Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients
G. Rossi (2000)
Human cytogenetics : a practical approach
D. Rooney (1986)
Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
M. Press (1993)
10.1007/s00277-001-0424-5
High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements
A. Pelz (2001)
10.1038/sj.leu.2401342
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7
H. Hasle (1999)
Deletion of two separate regions on chromosome 3p in breast cancers.
L. Chen (1994)
10.1093/HMG/1.8.625
Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
S. Joos (1992)
10.1053/GAST.1996.V111.PM8898652
Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.
Y. Takagi (1996)
10.1677/ERC.0.0080115
DNA methylation in breast cancer.
X. Yang (2001)
Contributions of A TM mutations to familial
YR Thorstenson (2003)
Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
N. H. Heintz (1990)
10.1007/978-3-642-57151-0_13
Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications.
C. Levenback (2000)
10.1093/JNCI/93.6.413
Filling the void: urinary markers for bladder cancer risk and diagnosis.
A. Gazdar (2001)
10.1016/S0022-5347(05)64835-5
Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique.
P. Tanis (2002)
10.1093/CLINCHEM/48.8.1178
Real-time PCR technology for cancer diagnostics.
P. Bernard (2002)
Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma.
P. Jonveaux (1996)
10.1016/S0145-2126(01)00197-7
Bcr-Abl variants: biological and clinical aspects.
A. Advani (2002)
10.1093/HMG/9.2.283
Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis.
G. Guanti (2000)
Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.
I. Wistuba (1997)
HER-2 Amplification and Topoisomcrase
A Di Leo (2002)
10.1126/SCIENCE.2565047
Allelotype of colorectal carcinomas.
B. Vogelstein (1989)
10.1038/bjc.1997.283
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
C. Charpin (1997)
10.1172/JCI108118
Free DNA in serum and plasma from normal adults.
C. R. Steinman (1975)
10.1043/0003-9985(1999)123<0620:HSLNBS>2.0.CO;2
Handling sentinel lymph node biopsy specimens.A work in progress.
M. Cibull (1999)
10.1126/SCIENCE.7604266
Mutations of GTBP in genetically unstable cells.
N. Papadopoulos (1995)
10.1002/1615-9861(200110)1:10<1200::AID-PROT1200>3.0.CO;2-Q
Laser capture microdissection and proteomics: Possibilities and limitation
R. Craven (2001)
10.1080/02841860152619115
The Inherited Basis of Human Radiosensitivity
R. Gatti (2001)
10.1038/sj.onc.1201222
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells
M. Pegram (1997)
10.1074/jbc.271.41.25089
Recognition of DNA Adducts by Human Nucleotide Excision Repair
D. Gunz (1996)
10.1093/AJCP/101.3.283
Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.
Y. Huh (1994)
10.1038/NM0696-682
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
L. Mao (1996)
10.1111/j.1749-6632.2001.tb03860.x
Microsatellite Alterations Detected in the Serum of Early Stage Breast Cancer Patients
B. Taback (2001)
10.1002/(SICI)1097-0142(19991001)86:7<1294::AID-CNCR26>3.0.CO;2-O
Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma
Tak Hong Cheung (1999)
10.1023/A:1008305412635
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.
R. González (2000)
10.1200/JCO.2001.19.2.354
Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.
A. Lebeau (2001)
10.1200/JCO.1999.17.7.1974
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer.
T. Jacobs (1999)
10.1097/00000478-199704000-00007
Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon.
M. Kang (1997)
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
J. Califano (2000)
p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts.
W. Tang (1999)
Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
Sang-Wook Choi (2002)
Molecular and pathological characterization of inherited breast cancer.
Borg A (2001)
10.1016/S0092-8674(00)80086-0
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
C. Barlow (1996)
Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma.
A. Hui (1996)
10.1136/jcp.49.1.15
Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.
A. Macedo (1996)
10.1097/00019606-199906000-00001
Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
R. Ghossein (1999)
eta!. 1999 lg V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
RN Damle (1999)
10.1038/35052073
Untangling the ErbB signalling network
Y. Yarden (2001)
10.1097/00001703-200202000-00008
Current surgical management of breast cancer
H. Cody (2002)
10.1155/2001/327047
Cancer Proteomics: The State of the Art
Paul C Herrmann (2001)
10.1097/00002371-200203000-00001
Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy
U. Keilholz (2002)
10.1002/ANR.1780320610
Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences.
J. Li (1989)
10.1093/nar/18.1.1
Eukaryotic topoisomerase II preferentially cleaves alternating purine- pyrimidine repeats
J. Spitzner (1990)
10.1038/NM0798-844
Tissue microarrays for high-throughput molecular profiling of tumor specimens
J. Kononen (1998)
10.1046/J.0007-1323.2001.01970.X
Detection of micrometastases in lymph nodes from patients with breast cancer
G. Branagan (2002)
10.1056/NEJM200011093431910
Pharmacogenomics--teaching old drugs new tricks.
J. Weinstein (2000)
10.1182/BLOOD.V99.5.1556
Clinical and biologic features of CD4(+)CD56(+) malignancies.
J. Feuillard (2002)
Microsatellite Alterations in Plasma DNA of Primary Breast Cancer Patients 1
J. Shaw (2000)
Inhaled isotretinoin
AR Dahl (2000)
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
J. Ross (1999)
The United Kingdom external quality assurance schemes (UK NEQAS) for leukaemia phenotyping
D Barnett (1994)
10.1007/978-3-642-61107-0_15
The CD44 proteins in embryonic development and in cancer.
L. Sherman (1996)
10.1067/MOB.2001.117401
An update on vulvar cancer.
G. Ghurani (2001)
10.1101/GAD.9.7.882
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
L. Donehower (1995)
10.1084/JEM.188.9.1641
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes
P. Romero (1998)
10.1007/s00464-002-9042-0
Thoracoscopic internal mammary sentinel node biopsy for breast cancer
Y. Ogawa (2002)
10.1016/0042-6822(77)90239-2
Human papilloma viruses (HPV): characterization of four different isolates.
L. Gissmann (1977)
10.1038/NG0997-79
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
S. Laken (1997)
10.1002/(SICI)1097-0320(19971015)30:5<249::AID-CYTO6>3.0.CO;2-C
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
B. H. Davis (1997)
10.1093/CARCIN/21.2.179
Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.
L. Wattenberg (2000)
10.1097/00000478-199903000-00003
Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.
R. Turner (1999)
10.1016/S0378-1119(02)00800-4
Characterization of the mouse hnRNP A2/B1/B0 gene and identification of processed pseudogenes.
J. Hatfield (2002)
10.1073/PNAS.92.11.4917
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
T. Golub (1995)
10.1016/S0167-4781(99)00054-8
Molecular characterization of a murine, major A/B type hnRNP protein: mBx.
A. Plomaritoglou (2000)
10.1016/0277-5379(87)90266-5
Isolation and characterization of DNA from the plasma of cancer patients.
M. Stroun (1987)
Allelotype of salivary gland tumors.
M. Johns (1996)
10.1016/S0959-437X(96)80030-X
The origin of interspersed repeats in the human genome.
A. Smit (1996)
10.1093/JNCI/90.20.1545
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
L. Mao (1998)
10.1016/S0002-9440(10)63028-3
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
X. Lin (2001)
10.1136/jmg.36.11.801
Genetic susceptibility to non-polyposis colorectal cancer
H. Lynch (1999)
10.1038/NG1196-255
Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours
R. Souza (1996)
The historical background of lymphatic mapping, in: Sentinel Lymph Node Biopsy, H.S.C
M Osbourne (2002)
Detection of high-risk HPV (16, 18, 33) in situ cancer of the cervix by PCR technique.
I. Pete (2002)
10.1001/ARCHDERM.1987.01660260111026
Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.
K. Kraemer (1987)
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
M. Esteller (2000)
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
S. Eissa (1997)
10.1097/00004836-199707000-00018
Hyperplastic (metaplastic) polyposis of the colorectum associated with adenomas and an adenocarcinoma.
S. Orii (1997)
Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom ALL Trial XI (MRCUK ALL XI)
IM Hann (1998)
10.1111/j.1749-6632.1995.tb24838.x
The Molecular Basis of Oncogenes and Tumor Suppressor Genes
R. Weinberg (1995)
10.1016/S0092-8674(00)81547-0
The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder
G. Stewart (1999)
10.1016/0022-1759(75)90106-4
Radioimmunoassay for nanogram quantities of DNA.
S. León (1975)
10.1056/NEJM200002243420801
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S. Braun (2000)
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
M. Dodson (1993)
10.1056/NEJM200201103460211
Lung cancer--time to move on from chemotherapy.
D. Carney (2002)
A minute chromosome in human chronic myelocytic leukemia (CML)
PC Nowell (1960)
Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.
L. Harris (2001)
10.1016/S0959-8049(97)10073-9
Significance of cell proliferation measurement in gastric cancer.
D. Schipper (1998)
10.1016/0005-2787(70)90751-3
Immunochemical measurement of DNA in nucleoprotein with the use of anti-DNA antibodies from patients with systemic lupus erythematosus.
B. D. Stollar (1970)
10.1046/j.1365-2141.1999.01377.x
THE AML1‐ETO CHIMAERIC TRANSCRIPTION FACTOR IN ACUTE MYELOID LEUKAEMIA: BIOLOGY AND CLINICAL SIGNIFICANCE
J. Downing (1999)
10.1136/jmg.35.12.978
Genetic implications of double primary cancers of the colorectum and endometrium.
T. Pal (1998)
10.1038/85798
DNA double-strand breaks: signaling, repair and the cancer connection
K. Khanna (2001)
10.1038/sj.leu.2402412
Identification of novel targets for cancer therapy using expression proteomics
S. Hanash (2002)
10.1136/jcp.55.12.940
Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry
P. Jain (2002)
10.1002/(SICI)1097-0142(19980901)83:5<896::AID-CNCR14>3.0.CO;2-Q
Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue
K. Otori (1998)
Allelotype analysis of cervical carcinoma.
A. Mitra (1994)
10.1093/NAR/26.14.3418
hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA.
L. Rajagopalan (1998)
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
G. Deng (1999)
10.1089/106652701752236232
Unfolding of Microarray Data
A. Goryachev (2002)
Heterogeneous Nuclear Ribonucleoprotein A2/B1 and Lung Cancer
L. Long (2003)
10.1016/0888-7543(92)90285-Z
Survey of human and rat microsatellites.
J. Beckman (1992)
10.1016/S0959-437X(97)80124-4
DNA excision repair pathways.
T. Lindahl (1997)
10.1002/GCC.2870120211
Loss of heterozygosity in sporadic primary cutaneous melanoma
E. Healy (1995)
10.1182/BLOOD.V85.9.2289.BLOODJOURNAL8592289
Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.
P. Liu (1995)
10.1016/S0959-437X(99)00039-8
RecQ family helicases: roles in cancer and aging.
J. Karow (2000)
10.1016/0022-2836(92)90096-3
Telomere end-replication problem and cell aging.
M. Levy (1992)
10.1038/sj.onc.1204591
E2A-HLF usurps control of evolutionarily conserved survival pathways
M. Seidel (2001)
10.1038/87876
Breast cancer genetics: What we know and what we need
K. Nathanson (2001)
New consistent chromosomal abnormality in chronic myelogenous leukemia
JD Rowley (1973)
10.1002/(SICI)1097-0142(20000315)88:6<1410::AID-CNCR19>3.0.CO;2-X
Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas
Y. Utada (2000)
10.1073/PNAS.90.23.10914
Antioncogenes and human cancer.
A. Knudson (1993)
Sentinel Lymph Node Biopsy for Breast Cancer: Pathologic Aspects, in Sentinel Lymph Node Biopsy, H.S.C
R. Turner (2002)
10.1128/MCB.12.10.4758
Analysis of the defect in DNA end joining in the murine scid mutation.
J. Harrington (1992)
10.1073/PNAS.78.11.7096
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.
S. Korsmeyer (1981)
10.1046/j.1524-4741.2000.98114.x
Selective Modulation of Paracortical Dendritic Cells and T‐Lymphocytes in Breast Cancer Sentinel Lymph Nodes
R. R. Huang (2000)
10.1016/S0960-7404(98)00023-1
Lymphatic mapping and sentinel lymph node biopsy in the staging of melanoma.
M. Edwards (1998)
10.1136/gut.50.6.857
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
R. Phillips (2002)
10.1007/BF03262036
The Present and Future of Molecular Diagnostics
D. Leonard (2001)
10.1182/BLOOD-2002-01-0230
Immunophenotypic clustering of myelodysplastic syndromes.
M. Maynadié (2002)
Transcriptionally active chimeric gene derived from the fusion of the AML gene and a novel gene on chromosome 8 in t(8;21) leukemic cells.
P. Nisson (1993)
10.1073/PNAS.90.8.3231
Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.
A. Gudkov (1993)
[Immunophenotypic analysis in the diagnosis of malignant lymphoma].
R. Ichinohasama (2000)
Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
M. Gonzalgo (1997)
10.1073/PNAS.68.4.820
Mutation and cancer: statistical study of retinoblastoma.
A. Knudson (1971)
10.1182/blood.v94.6.1848
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
T. Hamblin (1999)
Testing for HER2 status. Oncology
W. Hanna (2001)
10.1002/(SICI)1097-0142(19970301)79:5<900::AID-CNCR5>3.0.CO;2-F
Detection of K‐ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas
H. Kondo (1997)
10.1016/S0140-6736(98)04058-6
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
J. J. M. Dongen (1998)
10.1111/j.1365-2141.1994.tb05029.x
Translocation t(5;12)(q31‐q33;p12‐p13): a non‐random translocation associated with a myeloid disorder with eosinophilia
L. Baranger (1994)
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.
H. Kim (1994)
10.1111/j.1749-6632.2000.tb06585.x
Plasma DNA K‐ras Mutations in Patients with Gastrointestinal Malignancies
H. Mulcahy (2000)
10.1046/j.1365-2141.1999.01425.x
An investigation of the t(12;21) rearrangement in children with B‐precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods
H. Kempski (1999)
Overian cancer: loss of heterozygosity frequently occurs in the A TM gene, but structural alterations do not occur in this gene. Oncology
M Koike (1999)
10.1086/301673
Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.
M. Telatar (1998)
10.1073/PNAS.86.8.2766
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
M. Orita (1989)
10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2
Colorectal carcinoma associated with serrated adenoma – prevalence, histological features, and prognosis
M. Mäkinen (2001)
Isolation and characterization of eDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase
T. Fujii Hand Shimada (1989)
10.1016/S0079-6603(08)60723-0
Genetic disorders associated with cancer predisposition and genomic instability.
C. Vessey (1999)
Abnormal patterns of expression of CD16 (FeR-III) and CD 11 b (CRill) antigens by developing neutrophils in the bone marrow patients with myelodysplastic syndrome
KL Bowen (1997)
10.1016/S0145-2126(98)00185-4
Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
J. Nomdedéu (1999)
10.1126/SCIENCE.8052857
Transformation of mammalian cells by constitutively active MAP kinase kinase.
S. J. Mansour (1994)
10.1016/0090-4295(84)90138-9
Sentinel lymph node biopsy for staging penile cancer.
J. E. Fowler (1984)
Loss of heterozygosity at 11q22-q23 in breast cancer.
S. L. Carter (1994)
10.1056/NEJM199805213382101
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L. Aaltonen (1998)
10.1002/(SICI)1097-0320(19990501)36:1<36::AID-CYTO5>3.0.CO;2-9
Nine color eleven parameter immunophenotyping using three laser flow cytometry.
M. Bigos (1999)
10.1155/S1110724302204027
Recombinational DNA Repair in Cancer and Normal Cells: The Challenge of Functional Analysis
H. Willers (2002)
10.1002/(SICI)1097-0320(19980801)32:4<286::AID-CYTO5>3.0.CO;2-G
Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
J. Piedras (1998)
10.1093/JNCI/90.18.1361
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.
S. Paik (1998)
10.1056/NEJM198811103191902
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
M. J. van de Vijver (1988)
10.1074/jbc.273.31.19877
Differential Effects of Heterogeneous Nuclear Ribonucleoprotein K on Sp1- and Sp3-mediated Transcriptional Activation of a Neuronal Nicotinic Acetylcholine Receptor Promoter*
Q. Du (1998)
10.1126/science.273.5274.494
Multicolor Spectral Karyotyping of Human Chromosomes
E. Schröck (1996)
10.1146/ANNUREV.MED.47.1.285
Clinical implications of the p53 gene.
D. Sidransky (1996)
Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
F. Moinfar (2000)
10.1046/j.1365-2141.1996.d01-1962.x
Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in The Netherlands
J. Kluin‐Nelemans (1996)
10.1200/JCO.2002.09.088
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.
K. Döhner (2002)
10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z
The genetic attributable risk of breast and ovarian cancer
E. Claus (1996)
10.1038/sj.onc.1202691
Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer
T. Hiramoto (1999)
Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
J. Ciudad (1998)
10.1002/(SICI)1098-2264(199910)26:2<134::AID-GCC5>3.0.CO;2-9
Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer
M. Emi (1999)
Implications of oncogenomics for cancer research and clinical oncology.
J. L. Herrmann (2001)
Microarrays. Data standards on the horizon.
R. Davenport (2001)
10.1002/JSO.10079
Prognostic value of c‐erbB2 expression in breast cancer
S. Tsutsui (2002)
10.1093/bioinformatics/17.9.857
Critical Assessment of Microarray Data Analysis: the 2001 challenge
K. Johnson (2001)
10.1002/(SICI)1097-0320(20000201)39:2<96::AID-CYTO2>3.0.CO;2-X
Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer.
W. Corver (2000)
A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.
I. Saeterdal (2001)
10.1080/09553002.1994.11772027
Cancer risks in A-T heterozygotes.
D. Easton (1994)
DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA
KARYOTYPE ABNORMALITIES (2001)
10.1016/S0302-2838(01)00007-0
Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer.
I. Kausch (2002)
10.1182/BLOOD.V83.9.2423.BLOODJOURNAL8392423
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
C. Bastard (1994)
10.1016/S0140-6736(94)91578-4
Risks of cancer in BRCA1-mutation carriers
D. Ford (1994)
10.1128/MCB.16.10.5276
A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
E. Tzahar (1996)
10.1126/SCIENCE.3798106
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D. Slamon (1987)
10.3109/10428199909083383
Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
S. Schwartz (1999)
10.1023/A:1008342420825
Microsatellite instability: application in hereditary non-polyposis colorectal cancer.
P. Saletti (2001)
10.1016/S0065-2776(08)60774-9
Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression.
V. Pascual (1991)
10.1038/NG0894-536
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
J. Issa (1994)
10.1006/BBRC.1999.1040
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo.
B. J. Hamilton (1999)
10.1056/NEJM199405053301802
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
H. Muss (1994)
10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4
Utilization of polymerase chain reaction technology in the detection of solid tumors
G. Raj (1998)
10.1093/AJCP/105.3.321
Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
S. Apple (1996)
10.1038/35056049
Chromosomal stability and the DNA double-stranded break connection
D. V. Gent (2001)
10.1056/NEJM198705213162101
Breast and other cancers in families with ataxia-telangiectasia.
M. Swift (1987)
10.1086/301903
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.
F. H. Fodor (1998)
The applications of FISH in tumor pathology.
M. Tibiletti (1999)
10.11501/3079805
Phenotypic difference of normal plasma cells from mature myeloma cells
原田 浩徳 (1993)
CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
N. Cascavilla (1998)
10.1002/ijc.21077
Association of hereditary hemorrhagic telangiectasia and hereditary nonpolyposis colorectal cancer in the same kindred
N. Goldschmidt (2005)
10.1093/CARCIN/21.3.453
Nucleotide excision repair and human syndromes.
J. de Boer (2000)
10.1002/HUMU.10156
ATM mutations on distinct SNP and STR haplotypes in ataxia‐telangiectasia patients of differing ethnicities reveal ancestral founder effects
C. Campbell (2003)
10.1016/S1535-6108(02)00016-8
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
M. Higuchi (2002)
10.1046/J.1523-1747.1998.00458.X
Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression.
R. Morita (1998)
10.1016/0006-291X(85)90390-0
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.
S. Goelz (1985)
10.1111/j.1365-2141.1990.tb06365.x
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)
R. Geller (1990)
10.1002/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H
Terminology and nomenclature for standardization in quantitative fluorescence cytometry.
L. Henderson (1998)
10.1016/S1470-2045(00)00149-2
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia.
M. O’Dwyer (2000)
10.1016/S0016-5085(97)70169-0
Prognostic value of chromosome 1p allelic loss in colon cancer.
O. A. Ogunbiyi (1997)
10.1093/AJCP/112.6.828
De novo CD5+ Burkitt lymphoma/leukemia.
C. W. Lin (1999)
10.2165/00003495-200262010-00008
Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.
K. McKeage (2002)
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
L. Mirabelli-Primdahl (1999)
10.1006/GYNO.2000.5930
Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study.
J. O’Boyle (2000)
10.1002/CYTO.10037
Using mRNA expression profiling to determine anticancer drug efficacy.
G. Los (2002)
10.1002/ELPS.1150181007
Microsatellite‐based cancer detection using capillary array electrophoresis and energy‐transfer fluorescent primers
Y. Wang (1997)
10.1016/S0022-1759(99)00116-7
A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry.
P. Smith (1999)
10.1046/j.1537-2995.2001.41020276.x
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
T. Lee (2001)
10.1097/00000478-199911000-00009
Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
K. A. Cataldo (1999)
10.1097/00000478-200207000-00009
Interobserver Interpretative Reproducibility of GOLDFISH, A First Generation Gold-Facilitated Autometallographic Bright Field In Situ Hybridization Assay for HER-2/neu Amplification in Invasive Mammary Carcinoma
R. Tubbs (2002)
Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
P. Cairns (1995)
10.1046/j.1365-2141.1997.2273044.x
The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up study
E. Matutes (1997)
10.1016/0092-8674(90)90186-I
A genetic model for colorectal tumorigenesis
E. Fearon (1990)
10.1002/(SICI)1098-2264(199908)25:4<403::AID-GCC15>3.0.CO;2-P
Frequent 4‐bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients
W. Friedl (1999)
10.1038/SJ.THJ.6200119
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies.
E. Rossmann (2001)
10.1182/BLOOD.V97.2.572
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse.
T. Carter (2001)
10.1083/JCB.23.1.53
MAMMALIAN CHROMOSOMES IN VITRO
T. Hsu (1964)
10.1016/S0002-9440(10)65012-2
The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.
M. Baens (2000)
10.1006/GYNO.2001.6175
Allele loss on chromosome 1p36 in epithelial ovarian cancers.
A. A. Alvarez (2001)
10.1086/302853
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
R. Moslehi (2000)
10.1182/BLOOD.V85.8.1985.BLOODJOURNAL8581985
Childhood monosomy 7: epidemiology, biology, and mechanistic implications.
S. Luna-Fineman (1995)
10.2210/pdb1hd0/pdb
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0 (HNRNP D0 RBD1), NMR
T. Nagata (2000)
10.1128/MCB.20.15.5425-5432.2000
In Vitro Properties of the Conserved Mammalian Protein hnRNP D Suggest a Role in Telomere Maintenance
A. Eversole (2000)
10.1146/ANNUREV.GENET.31.1.429
Consequences of chromosomal abnormalities in tumor development.
I. Sánchez-García (1997)
10.1002/1097-0142(19950115)75:2+<715::aid-cncr2820751416>3.0.co;2-y
Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging
M. Harris (1995)
10.1006/EXCR.1998.4299
Microsatellite instability in human cancer: a prognostic marker for chemotherapy?
N. Claij (1999)
Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Z. Zhou (1999)
10.1136/JCP.54.12.897
Neuroblastoma tumour genetics: clinical and biological aspects.
N. Bown (2001)
10.1016/S0959-437X(97)80117-7
MutS homologs in mammalian cells.
R. Fishel (1997)
10.1038/sj.bjc.6690495
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
J. Silva (1999)
10.1007/BF01714978
A classification of acute leukaemia for the 1990s
D. Catovsky (2005)
10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H
Lymph node micrometastases from breast carcinoma
K. Dowlatshahi (1997)
10.3109/00365529709011221
K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas.
G. Nusko (1997)
10.1007/BF02748179
The chromosome number in man
A. Chaudhuri (1963)
Endocrine-Related Cancer ( 2001 ) 8 191 – 195 Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer
M. Dowsett (2001)
10.1093/JNCI/94.11.852
Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.
S. Paik (2002)
10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L
Cancer risk in mutation carriers of DNA‐mismatch‐repair genes
M. Aarnio (1999)
10.1002/cncr.11043
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia
J. Madzo (2003)
10.1056/NEJM199808133390702
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
S. Narod (1998)
HMSH6 alterations in patients with microsatellite instability-low colorectal cancer.
Y. Parc (2000)
10.1007/BF02760862
Differential display of mRNA
J. S. Zhang (1998)
10.1586/14737159.1.2.201
Telomerase in human tumors: molecular diagnosis andclinical significance
R. Dahse (2001)
10.1159/000055398
Testing for HER2 Status
W. Hanna (2001)
10.1136/jcp.52.1.5
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?
H. Iino (1999)
10.1016/S0955-0674(00)00091-0
The Mre11 complex and ATM: collaborating to navigate S phase.
J. Petrini (2000)
10.1074/jbc.274.48.34389
Mutational Analysis of a Heterogeneous Nuclear Ribonucleoprotein A2 Response Element for RNA Trafficking*
T. Munro (1999)
Contributions of flow cytometry to the analysis of the myelodysplastic syndrome.
D. Miller (2001)
Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
A. Mutirangura (1998)
10.1073/PNAS.96.15.8681
CpG island methylator phenotype in colorectal cancer.
M. Toyota (1999)
10.1016/0165-1110(94)00013-3
The comet assay: a comprehensive review.
D. Fairbairn (1995)
10.1016/S0014-5793(97)00412-2
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions
I. Alroy (1997)
10.1042/BJ3190307
Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene.
T. Asano (1996)
10.1093/CLINCHEM/41.12.1854
DNA repair and epidemiology of basal cell carcinoma.
Larry Grossman (1995)
10.1182/BLOOD.V97.10.3210
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
L. Chaperot (2001)
10.1182/blood.v90.6.2465
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
J. S. San Miguel (1997)
10.1016/S1471-4914(01)02183-9
Using genetic variation to study human disease.
J. Taylor (2001)
Molecular detection of genetic alterations in the serum of colorectal cancer patients.
K. Hibi (1998)
10.1093/JNCI/93.11.858
Detecting colorectal cancer in stool with the use of multiple genetic targets.
S. Dong (2001)
Epidemiology of cancer in ataxiatelangiectasia, in: Ataxia-Telangiectasia-Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency
BD Spector (1982)
10.1136/gut.34.3.392
High frequency of K-ras mutations in sporadic colorectal adenomas.
E. A. McLellan (1993)
10.1016/S1055-3207(18)30120-0
New adjuvant therapy for colon cancer: justified hope or commercial hype.
E. Galanis (2000)
Novel bcl-2
YL Wang (1998)
10.1210/MEND.14.6.0473
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.
M. Garayoa (2000)
10.1200/JCO.2000.18.21.3651
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.
G. Pauletti (2000)
10.1097/00000658-200104000-00006
Ex Vivo Sentinel Node Mapping in Carcinoma of the Colon and Rectum
J. Wong (2001)
10.1073/PNAS.97.2.710
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.
M. Toyota (2000)
10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
R. Tice (2000)
10.1182/BLOOD.V88.11.4110.BLOODJOURNAL88114110
The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
S. Iida (1996)
10.1038/sj.leu.2402584
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation
M. Sánchez (2002)
10.1182/blood.v93.7.2167.407a35_2167_2172
Nonimmunoglobulin gene hypermutation in germinal center B cells.
H. Peng (1999)
10.1006/GYNO.1997.4844
High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
U. Beller (1997)
10.1007/BF01408073
Recommendations for standardized human pedigree nomenclature
R. Bennett (2005)
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
B. Taback (2001)
10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O
Diversity of ATM gene mutations detected in patients with ataxia‐telangiectasia
P. Concannon (1997)
10.1182/blood.v82.4.1277.1277
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
B. Robbins (1993)
CD 19 and immunophenotype of marrow plasma cell in monoclonal gammopathy of undetermined significance
M Zandecki (1995)
10.1038/35057062
Initial sequencing and analysis of the human genome.
E. Lander (2001)
10.1016/S0002-9440(10)65470-3
Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.
A. Balsari (1999)
10.1038/sj.leu.2401548
TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification
KW Maloney (1999)
A frequent alteration of p53 gene in carcinoma in adenoma of colon.
M. Ohue (1994)
World Health Organization Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues
ES Jaffe (2001)
Detection of minimal residual disease in acute leukemia patients.
J. V. van Dongen (1996)
10.1200/JCO.1999.17.10.3238
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
P. Bostick (1999)
ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.
R. Dittadi (1997)
10.1126/SCIENCE.2889267
Clonal analysis of human colorectal tumors.
E. Fearon (1987)
10.1016/S0165-6147(00)01713-2
Towards a pharmacology of DNA methylation.
M. Szyf (2001)
10.1182/BLOOD.V98.4.945
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
I. Lossos (2001)
10.1182/BLOOD.V93.11.3913.411K22_3913_3921
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
R. Gascoyne (1999)
10.12816/EJHM.2000.11028
Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
O. El-ahmady (2002)
10.1001/JAMA.1997.03550150046034
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
D. Shattuck-Eidens (1997)
Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1).
S. Laforgia (1993)
10.1101/GR.174801
Arrays of arrays for high-throughput gene expression profiling.
P. Zarrinkar (2001)
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
J. Weber (1989)
10.1200/JCO.1998.16.12.3768
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
C. Pui (1998)
10.1053/GAST.1996.V110.PM8536860
Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.
H. Iguchi (1996)
10.1038/sj.leu.2401506
Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia
S. Raynaud (1999)
10.1086/301670
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.
G. Parmigiani (1998)
10.3892/IJO.14.4.663
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
N. Harbeck (1999)
Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma.
F. A. Abdel-Reheim (1996)
10.1182/BLOOD.V94.10.3509.422K36_3509_3515
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
B. Falini (1999)
10.1074/JBC.M009471200
Potential Role for the BLM Helicase in Recombinational Repair via a Conserved Interaction with RAD51*
L. Wu (2001)
10.14288/1.0089375
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
M. P. Rosin (2000)
10.1111/J.1464-410X.1997.TB00799.X
The cadherin cell-cell adhesion pathway in prostate cancer progression.
R. Paul (1997)
ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.
S. Schichman (1994)
10.1016/0014-4827(68)90538-7
Chemical differentiation along metaphase chromosomes.
T. Caspersson (1968)
10.1097/00000658-199404000-00002
Overexpression of p53 and HER‐2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer
J. Marks (1994)
10.1007/BF00918137
Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia
R. Paganelli (2004)
10.1016/S0168-9525(99)01930-7
Insights into the functions of BRCA1 and BRCA2.
P. Welcsh (2000)
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
B. Taback (2003)
10.1172/JCI116189
Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis.
J. Chasis (1993)
10.1148/RADIOLOGY.186.2.8421750
Liposarcoma of the extremities: MR and CT findings in the histologic subtypes.
J. Jelinek (1993)
10.1056/NEJM198711053171904
Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
L. Weiss (1987)
10.1093/JNCI/92.17.1370
Micrometastases matter in new melanoma staging system.
C. McNeil (2000)
10.1093/emboj/19.13.3159
The ErbB signaling network: receptor heterodimerization in development and cancer
M. Olayioye (2000)
Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma.
A. Mutirangura (2001)
10.1038/35000501
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh (2000)
1983.Ataxia-telangiectasia. Search for a central hypothesis
RA Gatti (1983)
10.1097/00000478-200212000-00017
Flow Cytometry in Clinical Diagnosis, 3rd ed.
A. El-Naggar (2002)
10.1111/j.1365-2141.1995.tb05429.x
Increased expression of the PRAD‐1/CCND1 gene in hairy cell leukaemia
F. Bosch (1995)
10.1038/NM0296-169
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Bo Liu (1996)
10.1093/AJCP/100.5.534
Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.
M. Borowitz (1993)
10.1016/0092-8674(94)90332-8
Lymphocyte responses and cytokines
W. Paul (1994)
10.1073/PNAS.92.26.12050
Repair of x-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: joining of correct and incorrect ends.
M. Löbrich (1995)
Expanded range of 1lq23 breakpoints with differeng patterns of cyclin Dl expression in B-cell malignancies
SD Raynaud (1993)
Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
D. Dorfman (1994)
Disseminated tumor cells versus micrometastasis: definitions and problems.
P. Hermanek (1999)
10.1086/340426
High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization.
J. Veltman (2002)
CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
C. Dunphy (1997)
DNA damage and repair in vivo.
D. Brash (1978)
10.1074/jbc.273.22.13819
Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency*
H. Waterman (1998)
Free DNA in the serum of cancer patients and the effect of therapy.
S. León (1977)
10.1172/JCI6909
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
M. Dhodapkar (1999)
10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q
Occurrence of malignancy in immunodeficiency diseases: A literature review
R. Gatti (1971)
10.1159/000203669
The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency.
P. Kuiper‐Kramer (1997)
Clinical utility of DNA ploidy and cell proliferation measurements by flow cytometry
TE Witzig (2001)
10.1136/jmg.39.1.57
A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA
S. Saviozzi (2002)
10.1200/JCO.2002.05.121
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
D. Berry (2002)
10.1056/NEJM200007133430201
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P. Lichtenstein (2000)
10.1023/A:1020599810261
Impaired IgG Antibody Production to Pneumococcal Polysaccharides in Patients with Ataxia–Telangiectasia
O. Sanal (2004)
10.1016/S0022-1759(00)00219-2
Commercial high speed machines open new opportunities in high throughput flow cytometry (HTFC).
R. G. Ashcroft (2000)
10.1038/modpathol.3880228
Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma
J. Couturier (2000)
10.1016/0092-8674(93)90330-S
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
F. Leach (1993)
Human breast cancer: correlation study between HER-2/neu amplification and prognostic factors in an unselected population.
F. Descôtes (1993)
10.1136/gut.47.1.43
Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum
J. R. Jass (2000)
10.1097/00000658-199801000-00008
Prognostic significance of DNA replication errors in young patients with colorectal cancer.
J. Lukish (1998)
10.1182/BLOOD.V79.5.1282.1282
Histogenetic correlations between subcategories of small noncleaved cell lymphomas.
T. Yano (1992)
10.1016/S0962-8924(00)89075-3
Practical flow cytometry (3rd edn): by Howard M. Shapiro, Wiley-Liss 1995. £49.95 (542 pages) ISBN 0 471 303763
Z. Darzynkiewicz (1995)
10.1002/1097-0142(19820401)49:7<1500::AID-CNCR2820490732>3.0.CO;2-O
Familial juvenile colonic polyposis with associated colon cancer
P. Rozen (1982)
10.1101/SQB.1986.051.01.018
Cytogenetic analysis by in situ hybridization with fluorescently labeled nucleic acid probes.
D. Pinkel (1986)
10.1056/NEJM199112263252602
Incidence of cancer in 161 families affected by ataxia-telangiectasia.
M. Swift (1991)
Prognostic value of c-crbB2 overexpression
LC Hartmann (1994)
10.1016/s0889-8588(05)70257-4
Gene expression profiling. Methods and clinical applications in oncology.
E. Raetz (2001)
Is sa JPJ
A Rashid (2001)
10.1002/ijc.1298
Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens
M. Linnebacher (2001)
10.1007/s10434-000-0015-z
Sentinel Node Biopsy in Ductal Carcinoma In Situ Patients
S. Pendas (2000)
10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E
New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy
S. Castellví-Bel (1999)
Microsatellite alterations in serum DNA of patients with colorectal cancer.
K. Kölble (1999)
10.1038/NM0996-1033
Microsatellite alterations in plasma DNA of small cell lung cancer patients
X. Q. Chen (1996)
10.1126/SCIENCE.8484120
Genetic mapping of a locus predisposing to human colorectal cancer.
P. Peltomäki (1993)
10.1093/NAR/30.2.E1
Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells.
S. Collis (2002)
10.1016/J.YMGME.2003.09.008
Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression.
H. Chun (2003)
10.1093/AJCP/105.4.451
The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma.
M. N. Kilo (1996)
10.1006/JSRE.1999.5629
Meta-analysis of sentinel lymph node biopsy in breast cancer.
D. Miltenburg (1999)
10.1038/sj.onc.1203142
Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control
H. Willers (2000)
10.1016/S0959-8049(01)00434-8
Update on pharmacogenetics in cancer chemotherapy.
F. Innocenti (2002)
10.1038/sj.onc.1201466
Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation
R. Pinkas-Kramarski (1997)
Persistence of the AML 1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;2l) leukemia
J J urlander (1996)
10.1007/978-1-4757-3147-7_2
Sentinel lymphadenectomy in node negative breast cancer.
P. Haigh (2000)
10.1111/J.1365-2141.1995.TB08938.X
Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reaction
G. Turner (1995)
10.1093/NAR/25.19.3950
Growth-dependent and growth-independent translation of messengers for heterogeneous nuclear ribonucleoproteins.
O. Camacho-Vanegas (1997)
Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.
W. C. Athas (1991)
10.1038/sj.onc.1201603
ATM is usually rearranged in T-cell prolymphocytic leukaemia
M. Yuille (1998)
10.1097/00130404-200203000-00007
Polymerase Chain Reaction in the Staging of Solid Tumors
Eric G. Davis (2002)
10.1046/j.1365-2141.2001.02922.x
Quantification of TEL–AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia
S. Drunat (2001)
Assays for monitoring cellular immune responses to active immunotherapy of cancer.
T. Clay (2001)
10.1172/JCI116978
Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
P. Sorensen (1994)
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.
D. Jenne (1998)
10.1289/ehp.97105s4775
DNA mismatch repair gene mutations in human cancer.
P. Peltomäki (1997)
The A TM gene and susecptibility to breast cancer
I Vorechovsky (1996)
Laparoscopically-assisted intraoperative lymphatic mapping in endometrial cancer: preliminary results.
Z. Holub (2001)
Detection of mutant
MS Kopreski (1997)
Advances in Brief Genetic Progression Model for Head and Neck Cancer : Implications for Field Cancerization 1
J. Califano (2006)
10.1016/0092-8674(92)90611-F
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
E. Li (1992)
Clinical cytokine network cytometry.
J. Moore (2001)
10.1126/SCIENCE.280.5366.1086
Mutations in the SMAD4/DPC4 gene in juvenile polyposis.
J. Howe (1998)
10.1074/jbc.274.43.30510
Nuclear DEAF-1-related (NUDR) Protein Contains a Novel DNA Binding Domain and Represses Transcription of the Heterogeneous Nuclear Ribonucleoprotein A2/B1 Promoter*
R. Michelson (1999)
10.1001/ARCHSURG.1992.01420040034005
Technical details of intraoperative lymphatic mapping for early stage melanoma.
D. Morton (1992)
10.1038/nbt0402-393
Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays
Wei-Wen Cai (2002)
10.1038/13773
Familial endometrial cancer in female carriers of MSH6 germline mutations
J. Wijnen (1999)
10.1016/S0092-8674(00)80241-X
mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3′ End
D. Ostareck (1997)
10.1002/path.923
Methylation and colorectal cancer
A. Jubb (2001)
10.1002/path.889
Towards a novel classification of human malignancies based on gene expression patterns
Ash A. Alizadeh (2001)
10.1016/S0304-3835(02)00168-4
Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells.
Y. Yan-Sanders (2002)
10.1016/S0065-2660(08)60144-3
DNA breakage and repair.
P. Jeggo (1998)
10.1016/S0002-9440(10)64102-8
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
W. Samowitz (2001)
10.1309/97WN-W6UX-XJWT-02H2
Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.
A. Rhodes (2002)
10.1016/0959-8049(92)90468-H
Stability of K-ras mutations throughout the natural history of human colorectal cancer.
L. Losi (1992)
10.1038/modpathol.3880007
Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ Hybridization
R. Jiménez (2000)
10.1016/S0002-9440(10)64872-9
Concordant CpG island methylation in hyperplastic polyposis.
A. Chan (2002)
10.1002/(SICI)1097-0320(19971015)30:5<231::AID-CYTO3>3.0.CO;2-K
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations.
C. Stewart (1997)
10.1126/SCIENCE.7792600
A single ataxia telangiectasia gene with a product similar to PI-3 kinase.
K. Savitsky (1995)
10.1016/S0002-9440(10)64785-2
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.
M. Tanner (2000)
10.1177/172460080101600401
Immunohistochemistry and Reverse Transcriptase Polymerase Chain Reaction on Sentinel Lymph Nodes can Improve the Accuracy of Nodal Staging in Breast Cancer Patients
G. Péley (2001)
No evidence for constitutional A TM mutation
J Bay (1998)
10.1093/JNCI/94.18.1358
Cancer Incidence in BRCA1 mutation carriers.
D. Thompson (2002)
10.1016/0165-4608(91)90229-N
Chromosome analysis of 96 uterine leiomyomas.
N. Pandis (1991)
10.11389/JJRS1963.28.1085
[Plasma DNA level as a tumor marker in primary lung cancer].
A. Maebo (1990)
10.1002/1097-0142(19931115)72:10<2873::AID-CNCR2820721003>3.0.CO;2-A
Nasopharyngeal carcinoma: Genetic changes, epstein–barr virus infection, or both: A clinical and molecular study of 36 patients
P. H. Choi (1993)
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
C. Goessl (1998)
10.1200/JCO.1998.16.2.462
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
S. Sjögren (1998)
10.1006/BBRC.2000.4173
Interaction of hnRNP A2/B1 isoforms with telomeric ssDNA and the in vitro function.
H. Kamma (2001)
10.1016/S0140-6736(64)91209-7
ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.
R. D. Peterson (1964)
10.1200/JCO.1990.8.1.103
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
S. Paik (1990)
10.1002/(SICI)1096-9896(199703)181:3<281::AID-PATH777>3.0.CO;2-M
Genetic heterogeneity in sporadic colorectal adenomas
E. Saraga (1997)
10.1038/35013089
ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response
X. Wu (2000)
Location of several putative genes possibly involved in human breast cancer progression.
K. Driouch (1998)
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
M. Tada (1993)
10.1056/nejm198402023100510
Cytogenetic disorders.
J. Hamerton (1984)
10.1126/SCIENCE.3479843
The gene for familial polyposis coli maps to the long arm of chromosome 5.
M. Leppert (1987)
10.1093/AJCP/58.5.601
Serum DNA levels in patients with malignant disease.
E. Perlin (1972)
10.1007/BF02967613
Relevance and practicability of internal mammary sentinel node biopsy for breast cancer
M. Noguchi (2002)
Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
G. Rothe (1996)
10.1126/SCIENCE.2470152
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
D. Slamon (1989)
Condylomata acuminata and human genital cancer.
H. Zur Hausen (1976)
10.1093/CLINCHEM/21.3.407
Use of nucleic acid hybridization for specific detection of submicrogram quantities of DNA, and its application to human plasma.
C. R. Steinman (1975)
10.1038/sj.leu.2400772
Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications
C. Guglielmi (1997)
HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
R. Tiwari (1992)
10.1093/JNCI/89.23.1758
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M. Rodriguez-Bigas (1997)
10.1089/152581600750062291
Chromosomal aberrations characteristic for sAML/sMDS are not detectable by random screening using FISH in peripheral blood-derived grafts used for autologous transplantation.
M. Weber (2000)
10.1038/378789A0
Identification of the breast cancer susceptibility gene BRCA2
R. Wooster (1995)
Microsatellite instabilities at five chromosomes in primary breast tumors.
U. Patel (1994)
10.1046/j.1365-2141.2002.03228.x
The TEL‐AML1 real‐time quantitative polymerase chain reaction (PCR) might replace the antigen receptor‐based genomic PCR in clinical minimal residual disease studies 
in children with acute lymphoblastic leukaemia
V. de Haas (2002)
10.2741/SKACEL
Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer.
M. Skacel (2002)
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
J. F. Flores (1996)
10.1182/BLOOD.V99.5.1853
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.
J. S. San Miguel (2002)
A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
M. Ashiya (1997)
10.1016/S0003-3995(00)01028-5
Cytogenetic analysis from DNA by comparative genomic hybridization.
G. Tachdjian (2000)
10.1182/BLOOD.V89.6.2079
International scoring system for evaluating prognosis in myelodysplastic syndromes.
P. Greenberg (1997)
MALT lymphoma with t( 11; 18)(q21; q21) expresses nuclear bell 0 and fails to respond to H
MQ Du (2001)
10.1136/mp.52.1.47
Detection of immunoglobulin light chain mRNA by in situ hybridisation using biotinylated tyramine signal amplification.
G. King (1999)
Activation of 13-Catenin-Tcf signaling in colon
PJ Morin (1997)
10.1016/S1097-2765(00)80345-7
A Xenopus protein related to hnRNP I has a role in cytoplasmic RNA localization.
C. A. Cote (1999)
Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
D. Radford (1995)
10.1038/218652A0
Defective Repair Replication of DNA in Xeroderma Pigmentosum
J. Cleaver (1968)
Peltomaki P, Mecklin 1-P, eta
LA Aaltonen (1994)
10.1200/JCO.1994.12.5.909
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
C. Pui (1994)
10.1007/s002770050269
Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis
M. Witzens (1997)
10.1038/sj.bjc.6690601
Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients
K. Hickey (1999)
Chronic Myeloproliferative Disorders: Cytogenetic and Molecular Genetic Abnormalities [Book Review]
L. Affleck (2004)
Hereditary Cancer Syndromes, Counseling About Cancer
K. Schneider (2002)
10.1086/302999
Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.
E. K. Goldberg (2000)
10.3109/07853890109002069
Biochip technologies in cancer research
O. Kallioniemi (2001)
ATM and breast cancer
D Stoppa-Lyonnet (1998)
10.1002/MAS.10000
Monitoring 2-D gel-induced modifications of proteins by MALDI-TOF mass spectrometry.
M. Hamdan (2001)
10.1136/jcp.52.6.455
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.
J. R. Jass (1999)
10.1046/j.1365-2133.2002.04579.x
Expression of tyrosinase, MIA and MART‐1 in sentinel lymph nodes of patients with malignant melanoma
M. Hochberg (2002)
10.1097/00005792-199103000-00003
Ataxia‐Telangiectasia: An Interdisciplinary Approach to Pathogenesis
R. Gatti (1991)
10.1053/GAST.2000.20228
Very high risk of cancer in familial Peutz-Jeghers syndrome.
F. Giardiello (2000)
10.1146/ANNUREV.GENOM.1.1.409
DNA helicases, genomic instability, and human genetic disease.
A. J. van Brabant (2000)
10.1517/14622416.1.4.395
Recent trends in protein biochip technology.
S. Weinberger (2000)
10.1200/JCO.20.6.1692
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies.
M. Heinrich (2002)
NPM, in non-Hodgkin's lymphoma
HG Drexler (2000)
10.1111/j.1749-6632.2000.tb06596.x
Clinical Significance of Circulating DNA Microsatellite Markers in Plasma of Melanoma Patients
T. Nakayama (2000)
10.1093/AJCP/111.4.488
Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas.
R. Lai (1999)
10.1038/modpathol.3880582
Determination of HER2 Gene Amplification by Chromogenic In Situ Hybridization (CISH) in Archival Breast Carcinoma
J. Zhao (2002)
Flow cytometric analysis of the Vbrepertoire in healthy controls
R van den Beemd (2000)
10.1007/s002590100476
Penile lymphoscintigraphy for sentinel node identification
R. V. Valdés Olmos (2001)
10.1097/00062752-199907000-00006
Molecular diagnostics in the treatment of leukemia.
J. Rubnitz (1999)
10.1200/JCO.2001.19.2.329
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
S. Ménard (2001)
10.1083/JCB.137.1.27
A Role for the M9 Transport Signal of hnRNP A1 in mRNA Nuclear Export
E. Izaurralde (1997)
10.1002/(SICI)1097-0215(19990909)82:6<822::AID-IJC9>3.0.CO;2-I
Somatic genetic alterations (loh) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity
I. Zborovskaya (1999)
10.1200/JCO.20.6.1480
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
T. Frank (2002)
10.1093/JNCI/93.22.1747
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
C. Jerónimo (2001)
10.1007/S102420200030
[The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
L. Riccioni (2002)
10.1038/bjc.1991.100
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.
W. Gullick (1991)
10.1111/j.1365-2141.1990.tb07871.x
Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome
A. Geddes (1990)
10.1101/GAD.9.21.2659
The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event.
H. Min (1995)
10.1023/A:1011163211802
C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.
A. E. Pinto (2001)
10.1093/ANNONC/MDF146
E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
D. Hossfeld (2002)
Gene Expression Data Analysis and Modeling
S. Liang (1999)
10.1200/JCO.2001.19.3.645
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
S. Eppenberger-Castori (2001)
K-ras mutations in stool
GD Sorenson (2000)
10.1093/AJCP/94.1.115B
Flow Cytometry in Clinical Diagnosis
I. Check (1990)
10.1200/JCO.1998.16.7.2417
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T. Frank (1998)
10.1097/00000478-200007000-00014
Effect of formalin tissue fixation and processing on immunohistochemistry.
M. Werner (2000)
10.1111/j.1749-6632.2001.tb03870.x
Proteomic Approaches within the NCI Early Detection Research Network for the Discovery and Identification of Cancer Biomarkers
M. Verma (2001)
10.1002/1097-0142(20011215)92:12<2965::AID-CNCR10156>3.0.CO;2-A
Detection of HER‐2/neu (c‐erb B‐2) DNA amplification in primary breast carcinoma
H. Tsuda (2001)
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.
M. Kane (1997)
10.1016/S0002-9440(10)65651-9
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.
T. Fujiwara (1998)
10.1056/NEJM199612053352303
The DCC protein and prognosis in colorectal cancer.
D. Shibata (1996)
10.1074/JBC.271.18.10760
Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer
J. Zhou (1996)
The alkaline comet assay, and further
Singh (1988)
10.1016/S0002-9440(10)65710-0
Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
N. Aguilera (1998)
New methodologic approaches for immunophenotyping acute leukemias.
G. Basso (2001)
10.1016/S0093-7754(02)70125-5
Trastuzumab/chemotherapy combinations in metastatic breast cancer.
J. Ligibel (2002)
10.1128/MCB.4.12.2622
Enhanced gene expression by the poly(dT-dG).poly(dC-dA) sequence.
H. Hamada (1984)
10.1093/emboj/18.7.1939
Modulation of exon skipping by high‐affinity hnRNP A1‐binding sites and by intron elements that repress splice site utilization
M. Blanchette (1999)
10.1038/NG0596-123
BRCA2 germline mutations in male breast cancer cases and breast cancer families
F. Couch (1996)
10.1126/SCIENCE.1651563
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
I. Nishisho (1991)
10.1159/000049901
Global Analysis of Gene Expression: Methods, Interpretation, and Pitfalls
Ryan M. Fryer (2002)
10.1038/336577A0
Localization of an ataxia-telangiectasia gene to chromosome 11q22–23
R. Gatti (1988)
10.1007/s004230050185
Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery?
K. Maruyama (1999)
10.1038/modpathol.3880294
Applications of Molecular Diagnostics: Solid Tumor Genetics Can Determine Clinical Treatment Protocols
C. Cordón-Cardó (2001)
10.1016/S0093-7754(01)90108-3
Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer.
G. Hortobagyi (2001)
10.1002/(SICI)1098-2388(199910/11)17:3<168::AID-SSU5>3.0.CO;2-V
Surgical management of vulvar cancer.
M. Morgan (1999)
Missense mutations
SP Scott (2002)
10.1038/382499A0
Frameshift mutator mutations
S. Malkhosyan (1996)
10.1620/TJEM.193.181
Infrequent APC mutations in serrated adenoma.
R. Dehari (2001)
Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection.
E. Boder (1958)
10.1093/HMG/6.13.2309
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
P. Vehmanen (1997)
[Myelodysplastic syndrome--classification, prognosis and therapy].
J. Čermák (2002)
10.1038/bjc.1991.103
The long term prognostic significance of c-erbB-2 in primary breast cancer.
J. Winstanley (1991)
10.1200/JCO.20.3.719
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
C. Vogel (2002)
10.1093/HMG/10.11.1155
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay.
S. Pitts (2001)
10.1080/00313029700169494
Mixed epithelial polyps in association with hereditary non‐polyposis colorectal cancer providing an alternative pathway of cancer histogenesis
J. R. Jass (1997)
Acute myeloid leukemia M4 with inv(l6) (pl3q22) exhibits a specific immunophenotype with C02 expression
E Paietta (1993)
10.1016/S0002-9440(10)65399-0
Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.
J. Y. Li (1999)
10.1182/BLOOD.V96.7.2543.H8002543_2543_2549
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
N. Schneider (2000)
10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8
Translational control of the proteome: Relevance to cancer
K. Dua (2001)
10.1038/sj.leu.2402568
Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
G. Buchonnet (2002)
10.1046/J.1365-2168.1997.02781.X
Incidence of hereditary non‐polyposis colorectal cancer in a population‐based study of 1137 consecutive cases of colorectal cancer
D. Evans (1997)
Aging and DNA methylation in colorectal mucosa and cancer.
N. Ahuja (1998)
Evidence for ATM as a tumor suppressor gene in T-prolymphocytic leukemia
S Stilgenbauer (1997)
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
P. Cairns (2001)
10.1073/PNAS.89.10.4452
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.
Y. Miyoshi (1992)
10.3181/00379727-220-44347
The Role of Alternative Pre-mRNA Splicing in Regulating the Structure and Function of Skeletal Protein 4.1
J. Conboy (1999)
10.3109/07357900009023065
Chromosome Breaks and Genomic Instability
M. Jasin (2000)
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
J. Almeida (1999)
10.1002/IJC.2910490109
Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
F. Rilke (1991)
10.1182/BLOOD.V96.4.1287.H8001287_1287_1296
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
D. Sainty (2000)
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.
W. Grady (1998)
10.1002/ART.1780160108
Detection of circulating DNA by counterimmunoelectrophoresis (CIE).
G. Davis (1973)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
H I 08. Cave (1998)
10.1093/QJMED/93.7.391
Impact of genomics on drug discovery and clinical medicine.
G. Emilien (2000)
10.1016/S0002-9440(10)65560-5
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
M. Tanner (1998)
10.1016/S0092-8674(00)80173-7
A Novel Receptor-Mediated Nuclear Protein Import Pathway
V. W. Pollard (1996)
Immunohistochemical analysis of p53 overexpression in human colonic tumors.
E. Darmon (1994)
10.1200/JCO.1998.16.2.427
Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
O. A. Ogunbiyi (1998)
10.1182/BLOOD.V95.8.2651.008K03_2651_2658
Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia
J. Donovan (2000)
10.1136/gut.34.5.621
p53 expression and K-ras mutation in colorectal adenomas.
N. Scott (1993)
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
F. Mertens (1997)
10.1093/emboj/18.14.4060
hnRNP A/B proteins are required for inhibition of HIV‐1 pre‐mRNA splicing
M. Caputi (1999)
10.1016/S0002-9610(98)00276-1
Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
F. Nwariaku (1998)
10.1136/mp.53.2.64
Laser capture microscopy
S. Curran (2000)
10.1586/14737159.1.4.383
Microsatellites: perspectives and potentials of mass spectrometric analysis
D. van den Boom (2001)
10.1046/j.1365-2559.2000.01028.x
Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum
J. R. Jass (2000)
10.1126/SCIENCE.1073834
Biallelic Inactivation of BRCA2 in Fanconi Anemia
N. G. Howlett (2002)
10.1097/00000478-199611000-00004
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.
J. Seidman (1996)
10.1182/BLOOD.V87.2.423.BLOODJOURNAL872423
Leukemia and lymphoma in ataxia telangiectasia.
A. Taylor (1996)
10.1056/NEJM199810013391401
The sentinel node in breast cancer--a multicenter validation study.
D. Krag (1998)
Cytogenetics and molecular biology of soft tissue tumors.
J. Fletcher (1996)
10.1002/1097-0142(20011201)92:11<2811::AID-CNCR10101>3.0.CO;2-T
Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma
M. Sánchez-Carbayo (2001)
10.1111/j.1749-6632.2000.tb06584.x
Diagnostic Value of K‐ras Mutations in Serum of Pancreatic Cancer Patients
L. Theodor (2000)
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
O. Serova (1997)
10.1177/1099800402238332
Major Histocompatibility Complex (MHC) Tetramer Technology: An Evaluation
Carolyn M Constantin (2002)
Deletion of the human T -cell receptor d-gene by a site-specific recombination. Nature
JP de Villartay (1988)
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
E. Levy-Lahad (1997)
10.1038/276790a0
The arrangement and rearrangement of antibody genes
J. Seidman (1978)
10.1177/002215540104900801
Antigen Retrieval Techniques
S. Shi (2001)
10.4049/jimmunol.170.7.3707
ATM Is Not Required in Somatic Hypermutation of VH, but Is Involved in the Introduction of Mutations in the Switch μ Region1
Q. Pan-Hammarström (2003)
The Pezcoller lecture: cancer cell cycles revisited.
C. Sherr (2000)
10.1002/(SICI)1097-0142(19960101)77:1<44::AID-CNCR9>3.0.CO;2-N
Histopathological studies of superficial‐type early colorectal carcinoma
R. Wada (1996)
10.1182/blood.v90.8.2863
Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.
C. D. Jennings (1997)
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
A. Biondi (1995)
10.1023/A:1006111117877
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
M. Pegram (2004)
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
D. Salonga (2000)
Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.
S. Noura (2002)
10.1002/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q
A micromorphometry‐based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma
H. Starz (2001)
Minimal residual disease in acute myeloid malignancies, in Textbook of malignant hematology
JF San Miguel (1998)
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
L. Picker (1987)
10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0
Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome
J. Risinger (1996)
10.1056/NEJM199305063281805
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
F. Giardiello (1993)
10.1016/S0165-4608(96)00328-7
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.
P. Athma (1996)
10.1046/j.1365-2141.2001.02558.x
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory
D. Holyoake (2001)
10.1016/S0168-9525(97)01244-4
Genome screening by comparative genomic hybridization.
F. Forozan (1997)
10.1038/sj.leu.2401133
RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL
K. Tobal (1998)
10.1038/73439
A gene expression database for the molecular pharmacology of cancer
U. Scherf (2000)
10.1002/HUMU.10232
Independent mutational events are rare in the ATM gene: Haplotype prescreening enhances mutation detection rate
M. Mitui (2003)
10.1093/INTIMM/12.6.927
Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4(+) and CD8(+) T lymphocytes is ATM-independent.
M. Rivero-Carmena (2000)
10.1046/j.1365-2141.1998.00712.x
Large granular lymphocyte leukaemia occurring after renal transplantation
Teresa C. Gentile (1998)
10.1038/sj.leu.2401824
Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification
L. Zen (2000)
10.1128/MCB.14.1.735
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
S. Muthuswamy (1994)
10.1038/ng0496-368
Karyotyping human chromosomes by combinatorial multi-fluor FISH
M. Speicher (1996)
10.1016/S0959-8049(00)00402-0
The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker.
T. Cooke (2001)
10.1016/0021-9681(85)90074-8
The accuracy of patient reports of a family history of cancer.
R. Love (1985)
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
M. L. Le Beau (1989)
HER-2/neu amplification predicts poor survival in node-positive breast cancer.
A. Borg (1990)
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.
L. S. Friedman (1997)
10.1200/JCO.1988.6.11.1685
Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection.
M. Tockman (1988)
10.1053/CTRV.2000.0208
Prognostic and predictive factors in prostate cancer.
F. Hamdy (2001)
10.1016/S0092-8674(00)81174-5
Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
R. Varon (1998)
10.1093/JNCI/94.3.205
Dominant negative ATM mutations in breast cancer families.
G. Chenevix-Trench (2002)
10.1093/JNCI/91.7.599
Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
J. Califano (1999)
Pathology of the lymph nodes in patients with malignant melanoma.
A. Cochran (1994)
10.3109/10428199609051760
Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation.
M. Nolte (1996)
10.1016/S0002-9440(10)63994-6
Histopathological identification of colon cancer with microsatellite instability.
J. Alexander (2001)
10.1093/JNCI/94.22.1697
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
H. Chang (2002)
10.1002/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO;2-H
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.
G. T. Stelzer (1997)
10.1586/14737140.2.3.323
AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients
Antonio J. Grillo-López (2002)
10.1038/NG1096-185
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
B. Roa (1996)
Lymphatic mapping in the treatment of breast cancer.
C. Cox (1998)
10.1165/AJRCMB.23.5.4177
Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
Y. Man (2000)
10.1182/blood.v84.7.2315.2315
CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
T. C. Gentile (1994)
10.1038/371075A0
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer
N. Nicolaides (1994)
10.1053/GAST.2002.35392
Emerging concepts in colorectal neoplasia.
J. Jass (2002)
10.1074/JBC.M007642200
Binding of an RNA Trafficking Response Element to Heterogeneous Nuclear Ribonucleoproteins A1 and A2*
J. Shan (2000)
Genetics of melanoma.
J. W. Fountain (1990)
10.1007/s00439-002-0748-9
Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers
W. Friedl (2002)
10.1016/S0025-6196(12)62360-X
Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
A. Tefferi (1988)
Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
L. Duncan (1998)
Standard polymerase chain reaction analysis does not detect t(14;18) in reactive lymphoid hyperplasia.
G. Segal (1994)
10.1046/j.1365-2141.1996.d01-1478.x
Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients
E. Matutes (1996)
10.1093/ANNONC/11.SUPPL_1.S17
Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L./WHO Classification.
E. Jaffe (2000)
Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
P. Cairns (1994)
10.7326/0003-4819-103-4-620
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.
J. Bennett (1985)
10.1043/0003-9985(2002)126<0816:TEIMMD>2.0.CO;2
Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
Jenny L Boyle (2002)
10.1182/blood.v70.4.926.926
Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia.
V. Brito-Babapulle (1987)
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
M. Paterson (1991)
10.1172/JCI105479
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.
E. Tan (1966)
Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
K. Takita (1992)
10.1038/34432
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
A. Hemminki (1998)
10.1073/PNAS.91.21.9871
Microsatellite alterations as clonal markers for the detection of human cancer.
L. Mao (1994)
10.1038/35060131
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation
H. Habelhah (2001)
10.1126/SCIENCE.7545954
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y. Miki (1994)
10.1046/j.1365-2141.1997.2133030.x
Complementarity determining region‐III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma
T. Kurokawa (1997)
10.1182/BLOOD.V87.3.1134.BLOODJOURNAL8731134
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.
F. Behm (1996)
Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
F. Lanza (1996)
10.1128/MCB.17.4.1776
An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
B. Chabot (1997)
10.1016/S1367-5931(00)00171-X
SNPing in the human genome.
C. Carlson (2001)
10.1046/j.1365-2141.1999.01236.x
Detection of abnormalities in B‐cell differentiation pattern is a useful tool to predict relapse in precursor‐B‐ALL
J. Ciudad (1999)
10.1038/modpathol.3880358
Sentinel Lymph Nodes Show Profound Downregulation of Antigen-Presenting Cells of the Paracortex: Implications for Tumor Biology and Treatment
Alistair J. Cochran (2001)
10.1038/sj.leu.2402060
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression
M. Tabernero (2001)
Loss of heterozygosity and p53 gene mutations in breast cancer.
G. Deng (1994)
10.1093/HMG/10.7.741
DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders.
P. Mohaghegh (2001)
10.1126/SCIENCE.2294591
Identification of a chromosome 18q gene that is altered in colorectal cancers.
E. Fearon (1990)
Monitoring cellular immune responses to cancer immunotherapy.
M. Morse (2001)
10.1007/BF01961241
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
C. Benz (2005)
10.1016/S1471-4914(02)02352-3
High-throughput protein arrays: prospects for molecular diagnostics.
G. Walter (2002)
10.1016/S0016-5085(98)70423-8
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
E. Martínez-López (1998)
10.1016/S1535-6108(02)00032-6
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
E. Yeoh (2002)
Single-nucleotide polymorphism analysis by MALDI-TOF
TJ Griffin (2000)
10.1074/jbc.M203633200
Distinct Sets of Adjacent Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1/A2 Binding Sites Control 5′ Splice Site Selection in the hnRNP A1 mRNA Precursor*
S. Hutchison (2002)
10.1016/0006-2952(68)90295-5
Role of nuclear antigens and antinuclear antibodies in inflammation.
E. Barnett (1968)
10.1016/S0002-9440(10)65499-5
Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.
A. Rosenwald (1999)
10.1093/AJCP/91.3.265
Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia.
M. Borowitz (1989)
Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
Y. Utada (2000)
10.1002/(SICI)1097-0215(19981005)78:2<153::AID-IJC5>3.0.CO;2-Y
Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma
A. Mutirangura (1998)
Human colorectal cancer: high frequency of deletions at chromosome 1p35.
I. Leister (1990)
10.1200/JCO.2002.08.400
Favorable impact of the t(9;11) in childhood acute myeloid leukemia.
J. Rubnitz (2002)
Evidence for genomic instability in human colonic aberrant crypt foci.
L. Augenlicht (1996)
10.1038/327298A0
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
K. Forrester (1987)
10.1097/00125480-200101000-00002
Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology?
H. Moch (2001)
10.1038/sj.leu.2401555
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
J. Pullen (1999)
10.1093/emboj/20.19.5443
SMN interacts with a novel family of hnRNP and spliceosomal proteins
Z. Mourelatos (2001)
10.1074/jbc.273.17.10784
Identification of Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) as a Repressor of C/EBPβ-mediated Gene Activation*
L. H. Miau (1998)
10.1076/opge.22.1.1.2236
Molecular characterization of the deletion in retinoblastoma patients with 13q14 cytogenetic anomalies
L. Lavanchy (2001)
10.1038/NG0997-96
Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia
I. Vorechovsky (1997)
Acute myeloid leukemia with 1lq23 trans locations: myelomonocytic immunophenotype by multi parameter flow cytometry
MR Baer (1998)
10.1006/EXCR.2002.5604
Intracellular trafficking of hnRNP A2 in oligodendrocytes.
C. Brumwell (2002)
10.1182/BLOOD.V88.3.1046.BLOODJOURNAL8831046
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
M. Hill (1996)
10.1634/THEONCOLOGIST.5-6-501
Uncovering functionally relevant signaling pathways using microarray-based expression profiling.
D. Harkin (2000)
10.1126/SCIENCE.275.5307.1784
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma
V. Korinek (1997)
10.4065/74.1.107-a
The Genetic Basis of Human Cancer
V. Michels (1999)
10.1073/PNAS.93.21.11757
Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.
J. Issa (1996)
10.1093/NAR/22.11.1996
Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1.
G. Biamonti (1994)
10.1159/000227338
Overexpression of p53 protein and proliferative activity in colorectal adenoma.
A. Yamaguchi (1994)
10.1038/225946A0
Autoradiographic Detection of Molecular Hybrids between rRNA and DNA in Tissue Sections
M. Buongiorno-Nardelli (1970)
10.1093/ANNONC/11.SUPPL_1.S3
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
N. Harris (2000)
10.1126/SCIENCE.8484121
Clues to the pathogenesis of familial colorectal cancer.
L. Aaltonen (1993)
10.1016/0092-8674(86)90803-2
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
N. Raab-Traub (1986)
10.1038/sj.leu.2401745
Immunoglobulin κ gene rearrangements between the κ deleting element and Jκ recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis
T. Seriu (2000)
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study.
H. Fee (1978)
10.1016/S1097-2765(01)00174-5
BRCA2 is required for homology-directed repair of chromosomal breaks.
M. Moynahan (2001)
10.1038/NG0293-113
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
F. Barr (1993)
Human epithelial ovarian cancer allelotype.
W. Cliby (1993)
Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
E. R. van Wering (1995)
The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
R. Thorpe (1997)
10.1046/J.1525-1438.2001.011004255.X
Surgical management of stage I and II vulvar cancer: The role of the sentinel node biopsy. Review of literature
A. Makar (2001)
10.1038/bjc.1993.114
Prognostic significance of c-erbB-2 expression in node negative breast cancer.
S. Bianchi (1993)
10.1023/A:1008375931236
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
N. Harris (1999)
Tumor-related free DNA microsatellites detected in breast cancer patients serum correlates with disease progression
B Taback (2000)
Cancer proteomics: from biomarker discovery to signal pathway profiling.
V. E. Bichsel (2001)
10.1074/JBC.M210184200
Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer* 210
P. Adam (2003)
10.1182/BLOOD.V87.3.1123.BLOODJOURNAL8731123
The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
F. O. Smith (1996)
10.1038/12511
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis
H. Lamlum (1999)
10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C
Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats.
M. Roederer (2001)
Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
D. Easton (1993)
10.1016/0092-8674(94)90322-0
Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
T. Golub (1994)
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms.
M. Yashiro (2001)
10.1016/J.MRFMMM.2004.05.016
Effect of Ku86 and DNA-PKcs deficiency on non-homologous end-joining and homologous recombination using a transient transfection assay.
M. B. Secretan (2004)
Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
L. De Benedetti (1993)
Optimizing the immunohistochemical assessment of HER-2 expression to predict HER-2 gene amplification with the HercepTest kit
KJ Bloom (2002)
10.1016/S0168-9525(97)01269-9
STAR, a gene family involved in signal transduction and activation of RNA.
C. Vernet (1997)
Ultrastaging of colorectal cancer by sentinel lymph node mapping technique--a multicenter trial.
S. Saha (2001)
Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.
K. W. Robertson (1996)
10.1182/BLOOD.V94.1.362.413A45_362_364
t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma.
A. Rosenwald (1999)
10.3109/10428199509056852
Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
C. Sperling (1995)
Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
M. Sánchez-Céspedes (2001)
The genetic basis of colorectal cancer risk.
D. Ahnen (1996)
Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
M. Hampl (1999)
Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
R. Reiter (1993)
10.1007/978-3-642-59537-0_8
The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
B. Taback (2001)
10.1016/S0046-8177(97)90230-6
Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
M. Nucci (1997)
10.1038/sj.leu.2401590
Leukemogenesis by CBF oncoproteins
AD Friedman (1999)
10.1200/JCO.1999.17.9.2639
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.
M. Cobleigh (1999)
10.1177/172460080101600201
Serum Tumor Markers: Past, State of the Art, and Future
C. Thomas (2001)
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
M. Berger (1988)
The incidence and gene frequency of ataxia-telangiectasia in the United States.
M. Swift (1986)
10.1146/ANNUREV.BIOCHEM.69.1.373
Protein tyrosine kinase structure and function.
S. Hubbard (2000)
10.1073/PNAS.95.9.5172
Homology-directed repair is a major double-strand break repair pathway in mammalian cells.
F. Liang (1998)
10.1093/JNCI/80.12.925
Examination of the role of cigarette smoke in lung carcinogenesis using multistage models.
M. Gaffney (1988)
10.1002/ijc.1434
Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis
R. von Knobloch (2001)
10.1016/S0959-8049(00)00395-6
c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease.
A. Jukkola (2001)
10.1007/s10434-999-0553-y
Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma
C. Cox (1999)
10.1046/j.1365-2141.2002.03469.x
Receptor tyrosine kinase mutations in myeloid neoplasms
R. Gupta (2002)
10.1097/00000658-199701000-00001
Recent advances in the care of the patient with malignant melanoma.
D. Reintgen (1997)
10.1016/J.AMJSURG.2003.10.028
Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
M. Kelley (2004)
10.1016/0003-2697(92)90429-B
Electroporation-mediated gene transfer efficiency is reduced by linear plasmid carrier DNAs.
J. Nickoloff (1992)
10.1016/S0167-7799(99)01401-8
Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry.
T. J. Griffin (2000)
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
H. Elsaleh (2001)
10.1038/sj.leu.2401279
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL
P. Lucio (1999)
10.1146/ANNUREV.IMMUNOL.15.1.177
The genetic defect in ataxia-telangiectasia.
M. Lavin (1997)
10.1046/j.1365-2141.1999.01501.x
The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease
D. Grimwade (1999)
10.1111/j.1749-6632.2000.tb06594.x
Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer
N. Bruhn (2000)
10.1016/0092-8674(82)90065-4
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
L. C. Padhy (1982)
10.1038/sj.onc.1200881
Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families
S. Seitz (1997)
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Y. Fujiwara (1999)
10.1038/nrc1011
ATM and related protein kinases: safeguarding genome integrity
Y. Shiloh (2003)
10.1182/BLOOD.V90.1.28.28_28_35
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
F. Uckun (1997)
10.1093/AJCP/112.3.319
Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry.
Paul J. Kurtin (1999)
10.1081/CNV-120001183
Applications of SKY in Cancer Cytogenetics
J. Bayani (2002)
10.1097/00019606-199802000-00003
Detection of Tyrosinase mRNA in Formalin‐fixed, Paraffin‐embedded Archival Sections of Melanoma, Using the Reverse Transcriptase In Situ Polymerase Chain Reaction
J. Guo (1998)
10.3109/10428190109097741
T-Cell Associated Antigen-Positive B-Cell Lymphoma
T. Inaba (2001)
10.1016/0092-8674(81)90021-0
Identification and characterization of the familial adenomatous polyposis coli gene
J. Groden (1991)
10.1002/(SICI)1097-0320(19990815)38:4<161::AID-CYTO3>3.0.CO;2-A
Four color compensation.
C. Stewart (1999)
BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
R. Soslow (1997)
First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer.
M. Medl (2000)
10.1097/00006254-200209000-00016
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
N. Kauff (2002)
A minute chromosome in human chronic granulocytic leukemia
P. Nowell (1960)
10.1016/S0047-6374(01)00248-2
Unwinding the molecular basis of the Werner syndrome
Jiang-Cheng Shen (2001)
10.1016/S0092-8674(01)00212-4
Lipoxygenase mRNA Silencing in Erythroid Differentiation The 3′UTR Regulatory Complex Controls 60S Ribosomal Subunit Joining
D. Ostareck (2001)
Lack of WRN results in extensive deletion at nonhomologous joining ends.
J. Oshima (2002)
10.1016/S0140-6736(02)07448-2
Counting alleles to predict recurrence of early-stage colorectal cancers
W. Zhou (2002)
10.1159/000012079
p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma
H. Elsaleh (2000)
10.1016/0092-8674(92)90477-T
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
A. Mayeda (1992)
Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.
M. Muto (1996)
10.1056/NEJM200008173430707
Epstein-Barr virus infection.
J. Cohen (2000)
10.1101/GAD.12.16.2522
The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.
A. Moreira (1998)
10.1101/GAD.9.14.1766
HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression.
X. Liu (1995)
10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S
MUTATION OF THE VHL GENE IS ASSOCIATED EXCLUSIVELY WITH THE DEVELOPMENT OF NON‐PAPILLARY RENAL CELL CARCINOMAS
C. Kenck (1996)
10.1046/J.1365-2257.1998.00141.X
Modern molecular diagnostics and the management of haematological malignancies.
G. Morgan (1998)
10.1182/BLOOD.V85.9.2528.BLOODJOURNAL8592528
Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.
J. Limpens (1995)
10.1016/S0959-8049(98)00306-2
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers.
P. Jernvall (1999)
10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.0.CO;2-Z
Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM
K. Laake (1997)
Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
J. Johannsdottir (1999)
10.1097/00000658-199111000-00015
Lymphatic drainage of skin to a sentinel lymph node in a feline model.
J. Wong (1991)
p16 gene alterations in nasopharyngeal carcinoma.
K. W. Lo (1995)
Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.
A. Melnick (1999)
10.1038/nature01368
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
C. Bakkenist (2003)
10.1182/BLOOD.V99.2.409
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
B. Falini (2002)
10.1016/0378-1119(94)00534-Y
Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment.
E. Berns (1995)
10.1002/(SICI)1097-0320(20000301)39:3<217::AID-CYTO7>3.0.CO;2-M
A novel deep red/low infrared fluorescent flow cytometric probe, DRAQ5NO, for the discrimination of intact nucleated cells in apoptotic cell populations.
M. Wiltshire (2000)
10.1016/S0014-5793(00)01674-4
Base excision repair of DNA in mammalian cells
H. Krokan (2000)
10.1016/S0889-8545(05)70227-8
Human papillomaviruses: into the new millennium.
E. Unger (2001)
10.1038/NG0396-333
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
S. Tavtigian (1996)
Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice.
A. Bishop (2000)
10.1093/CLINCHEM/18.6.519
Nucleic acid concentrations in normal human plasma.
R. Kamm (1972)
10.1016/S0962-8924(01)02149-3
Double-strand breaks and tumorigenesis.
A. Pierce (2001)
10.1093/ANNONC/MDI731
Biology and treatment of chronic lymphocytic leukemia.
P. Kokhaei (2005)
10.1056/NEJM200001133420201
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.
R. Gryfe (2000)
10.1182/BLOOD.V65.3.620.BLOODJOURNAL653620
Hairy cell leukemia: a tumor of pre-plasma cells.
K. Anderson (1985)
10.1038/NG0197-87
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis
Akseli Hemminki (1997)
10.1016/0304-419X(94)90012-4
The biology of erbB-2/neu/HER-2 and its role in cancer.
N. E. Hynes (1994)
10.1182/blood.v81.11.3043.3043
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
H. Adriaansen (1993)
Microsatcllite analysis of breast carcinoma
P Regitnig (2002)
10.1093/JNCI/90.18.1371
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B. Fisher (1998)
10.1016/S0091-679X(01)64023-8
Detection of minimal residual disease.
A. Deptała (2001)
10.1016/S1471-4914(02)02350-X
Challenges of single-cell diagnostics: analysis of gene expression.
R. Todd (2002)
10.3816/CBC.2002.N.017
The HER2 extracellular domain as a prognostic and predictive factor in breast cancer.
Raquel A Nunes (2002)
10.1006/GYNO.2001.6226
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
S. Barker (2001)
10.1002/(SICI)1097-0320(19980215)34:1<39::AID-CYTO7>3.0.CO;2-9
Report on the first Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia.
A. Ruiz-Argüelles (1998)
10.1002/1097-0320(20001015)42:5<296::AID-CYTO7>3.0.CO;2-X
Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma?
C. Dunphy (2000)
10.1182/BLOOD.V92.5.1728.417A01_1728_1734
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors.
S. Schnittger (1998)
10.1200/JCO.1992.10.4.599
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
D. Allred (1992)
10.1016/S1072-7515(99)00130-1
The role of sentinel lymph node biopsy in breast cancer.
S. Bass (1999)
10.1016/0090-4295(86)90004-X
Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma?
E. Wespes (1986)
Genetic and epigenetic modification of MLH 1 accounts for a major share of microsatellite unstable colorectal
S. Kuismanen (2000)
10.1016/S1097-2765(00)80202-6
Brca1 controls homology-directed DNA repair.
M. Moynahan (1999)
10.1126/SCIENCE.1651562
Identification of FAP locus genes from chromosome 5q21.
K. Kinzler (1991)
10.1002/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H
Detection of minimal residual disease in acute leukemia by flow cytometry.
D. Campana (1999)
10.1038/sj.bjc.6600008
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
A. Antoniou (2002)
10.1016/S0002-9440(10)64088-6
Molecular clonality of in-transit melanoma metastasis.
T. Nakayama (2001)
10.1089/HYB.1999.18.41
Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
S. Reinartz (1999)
10.1002/PATH.1711630205
Long‐term survival in breast cancer related to overexpression of the c‐erbB‐2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL‐CB11
R. Dykins (1991)
10.1016/0092-8674(83)90534-2
The human c-myc oncogene: Structural consequences of translocation into the igh locus in Burkitt lymphoma
J. Battey (1983)
10.1006/GYNO.1996.0211
Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study.
T. Burke (1996)
10.1093/JNCI/91.14.1241
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
E. Warner (1999)
10.1002/ijc.1027
Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy
Y. Harima (2001)
10.1128/MCB.21.20.6960-6971.2001
Versatile Role for hnRNP D Isoforms in the Differential Regulation of Cytoplasmic mRNA Turnover
N. Xu (2001)
10.1097/00000478-200102000-00005
Hyperplastic Polyposis: Association With Colorectal Cancer
B. Leggett (2001)
Immunophenotypic analysis of the leukemic phase of mycosis fungoides
J Carey (1989)
10.1016/S0093-7754(02)70123-1
Trastuzumab cardiotoxicity: Speculations regarding pathophysiology and targets for further study.
J. Schneider (2002)
1998.lnitial report of the SWOG biological correlative study of c-erbB-2 expression as a predictor of outcome in a trial comparing adjuvant CAF T with tamoxifin (T) alone
PM Ravdin (1998)
Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors.
L. Sainati (1997)
10.1111/j.1749-6632.2001.tb03861.x
A Possible Noninvasive Method for the Detection of Bladder Cancer in Patients
M. Utting (2001)
10.1097/00000478-199607000-00006
Nodal nevi and cutaneous melanomas.
K. Carson (1996)
10.1101/GAD.13.20.2633
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.
A. Pierce (1999)
DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
H. Takebe (1977)
10.3816/CBC.2000.N.002
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
J. Sparano (2000)
10.1200/JCO.2001.19.11.2948
Gene discovery using the serial analysis of gene expression technique: implications for cancer research.
K. Polyak (2001)
10.1056/NEJM200012283432602
Genomic aberrations and survival in chronic lymphocytic leukemia.
H. Döhner (2000)
10.1093/JNCI/93.21.1633
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L. Hartmann (2001)
10.1093/NAR/24.11.2053
Extrachromosomal recombination occurs efficiently in cells defective in various DNA repair systems.
C. Morrison (1996)
10.1097/00019606-199300020-00035
Rearrangement of the BCL‐2 Gene in Follicular Lymphoma: Detection by PCR in Both Fresh and Fixed Tissue Samples
J. Liu (1993)
10.1136/gut.38.4.578
Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
F. Giardiello (1996)
10.1093/AJCP/105.1.31
CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
J. Ferry (1996)
10.1016/S0065-230X(08)60097-4
Mutations predisposing to hereditary nonpolyposis colorectal cancer.
P. Peltomäki (1997)
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.
R. Zeillinger (1989)
10.1002/1097-0142(20010601)91:11<2148::AID-CNCR1243>3.0.CO;2-G
Increased genetic damage in oral leukoplakia from high risk sites
L. Zhang (2001)
10.1038/549
Positional cloning of the gene for Nijmegen breakage syndrome
S. Matsuura (1998)
Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
A. Smith (1994)
Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
M. Mullokandov (1996)
10.1002/(SICI)1096-9896(199612)180:4<357::AID-PATH710>3.0.CO;2-D
Ki‐ras MUTATIONS IN ADENOMAS: A CHARACTERISTIC OF CANCER‐BEARING COLORECTAL MUCOSA
R. G. Morris (1996)
10.1111/j.1749-6632.1993.tb38775.x
Fluorescence Spectral Overlap Compensation for Any Number of Flow Cytometry Parameters
C. Bagwell (1993)
10.1046/j.1365-2559.2002.01512.x
Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies
R. Gutzmer (2002)
10.1038/35101031
Two genetic hits (more or less) to cancer
A. Knudson (2001)
Detection of minimal residual disease in acute myeloid leukemia: methodologic advances and clinical significance
D Ill.Campana (1995)
10.1053/GAST.2000.9361
Phenotypic and molecular characteristics of hyperplastic polyposis.
A. Rashid (2000)
10.1056/NEJM199705153362002
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F. Couch (1997)
10.1146/ANNUREV.BI.65.070196.001031
DNA repair in eukaryotes.
R. Wood (1996)
10.1023/A:1012938825396
Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure
V. Tjan-Heijnen (2004)
High resolution analysis of chromosome 3p alterations in cervical carcinoma.
A. A. Larson (1997)
Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
R. Lai (1998)
10.1016/S0079-6107(98)00047-9
Structural analysis of receptor tyrosine kinases.
S. Hubbard (1999)
10.1016/0888-7543(89)90343-1
Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.
N. Popescu (1989)
10.2307/3578657
DNA double-strand breaks induced by high-energy neon and iron ions in human fibroblasts. I. Pulsed-field gel electrophoresis method.
B. Rydberg (1994)
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
R. Fishel (1993)
10.1016/0046-8177(94)90085-X
Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas.
G. Segal (1994)
10.1046/j.1365-2141.1998.00871.x
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
C. Guglielmi (1998)
10.1182/blood.v73.7.1759.bloodjournal7371759
Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas.
B. Ngan (1989)
10.1007/BF02053699
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
H. Vasen (1991)
The surgical treatment of cancer of the sigmoid flexure and rectum
B. Moynihan (1908)
10.1002/1097-0142(19890815)64:4<950::AID-CNCR2820640430>3.0.CO;2-O
Flat early cancers of the large intestine
S. Kuramoto (1989)
10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5
Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review
H. Lynch (1996)
10.1073/PNAS.90.17.7915
Oxidants, antioxidants, and the degenerative diseases of aging.
B. Ames (1993)
10.1038/sj.leu.2402918
High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities
S. Ishizawa (2003)
Analysis ofloss
P O'Connell (1998)
A method for simultaneous quantification of monoclonal antibody Ki-67 and DNA content by flow cytometry. Application to breast carcinomas.
M. Gorisse (1999)
Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.
K. Lee (1999)
10.1016/S0959-8049(00)00110-6
Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer.
H. Anton-Culver (2000)
10.1016/S0959-8049(00)00152-0
Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.
R. Ghossein (2000)
10.1038/labinvest.3780347
Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations
A. Hoos (2001)
10.1056/NEJM200102223440801
Gene-expression profiles in hereditary breast cancer.
I. Hedenfalk (2001)
10.1016/S0027-5107(98)00104-3
DNA double-strand breaks, chromosomal rearrangements, and genomic instability.
W. Morgan (1998)
10.1006/EXCR.2000.4827
The RGG domain in hnRNP A2 affects subcellular localization.
R. Nichols (2000)
Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer.
H. Yamamoto (1998)
Prognostic and predic
M Giai (1994)
10.1006/JMBI.1993.1127
Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter.
G. Biamonti (1993)
10.1016/S0002-9440(10)61695-1
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis.
M. Guidoboni (2001)
10.1038/368258A0
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer
C. E. Bronner (1994)
Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
M. Sanchez-Cespedes (1997)
10.1016/S0165-4608(02)00648-9
Cytogenetic study of non-Hodgkin lymphoma from South India. histologic and geographic correlations.
P. Kumari (2003)
10.1111/1523-1747.EP12606207
DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma.
Q. Wei (1995)
10.1016/S0140-6736(98)10117-4
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
T. Stankovic (1999)
Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.
M. Pedroni (2001)
10.1007/BF02281864
Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein
W. Friedl (2005)
Clinical molecular cytometry: Merging flow cytometry with molecular biology in laboratory medicine
J. McCoy (2001)
10.1002/ijc.1571
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
P. Pisani (2002)
The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
A. Orfao (1999)
10.1016/S1043-321X(99)92004-0
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
P. Ravdin (1999)
10.1002/(SICI)1097-0215(19971009)73:2<225::AID-IJC11>3.0.CO;2-E
Detailed microsatellite analysis of chromosome 3p region in non‐papillary renal cell carcinomas
J. Chudek (1997)
10.1093/JNCI/78.3.399
Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
A. Cochran (1987)
10.1093/AJCP/107.4.430
Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
R. Alsabeh (1997)
10.1007/978-3-642-57066-7_5
Pax-5/BSAP: regulator of specific gene expression and differentiation in B lymphocytes.
J. Hagman (2000)
10.1016/S1097-2765(01)00173-3
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
I. García-Higuera (2001)
10.1002/(SICI)1098-2264(199906)25:2<169::AID-GCC13>3.0.CO;2-I
Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization
Y. Chen (1999)
10.1093/AJCP/107.6.653
Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
K. Mann (1997)
Zi1z N, Beazer-Barclay Y, eta
SM Powell (1992)
10.1016/S1040-8428(99)00032-3
Immunophenotypical detection of minimal residual disease in acute leukemia.
J. S. San Miguel (1999)
10.1097/00008390-200102000-00007
Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma?
H. Blaheta (2001)
10.1093/emboj/19.12.3090
Characterization of mammalian RAD51 double strand break repair using non‐lethal dominant‐negative forms
S. Lambert (2000)
10.1093/JNCI/91.15.1295
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
K. Halling (1999)
10.1097/00000478-198407000-00008
Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp.
S. Urbanski (1984)
Short mononucleotide repeat sequence variability in mismatch repair-deficient cancers.
L. Zhang (2001)
10.1046/j.1365-2141.1999.01685.x
High‐sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma
J. Almeida (1999)
THE USE OF MOLECULAR PROFILING TO PREDICT SURVIVAL AFTER CHEMOTHERAPY FOR DIFFUSE LARGE
Ing. (2002)
Classical ATM germline mutations
A Broeks (2000)
Early diagnosis of ataxia-telangiectasia
X Sun (2002)
10.1016/S0014-5793(00)01771-3
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics
Julio E. Celis (2000)
10.1038/NM0495-348
Genetic instability occurs in the majority of young patients with colorectal cancer
Bo Liu (1995)
10.1016/S0753-3322(97)83541-X
Epstein-Barr virus genes and cancer cells.
P. Farrell (1997)
Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.
N. Hayashi (1994)
10.1093/JNCI/88.15.1054
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
T. Jacobs (1996)
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
M. Béné (1995)
10.1093/NAR/20.24.6461
hnRNP A2/B1 binds specifically to single stranded vertebrate telomeric repeat TTAGGGn.
S. McKay (1992)
10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
J. Vandesompele (2001)
10.1093/JNCI/91.17.1475
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T. Rebbeck (1999)
10.1016/S1471-4914(02)02335-3
Modern molecular cytogenetic techniques in genetic diagnostics.
H. Toennies (2002)
The definition of the sentinel
G Carlson (2002)
10.1073/PNAS.96.8.4546
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.
N. Dupin (1999)
10.1002/CYTO.10008
Compensation is not dependent on signal intensity or on number of parameters.
M. Roederer (2001)
10.1016/0300-2977(94)00067-J
Colonic adenocarcinoma in a patient with multiple hyperplastic polyps.
R. Lieverse (1995)
10.1002/j.1460-2075.1994.tb06883.x
Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins.
A. Mayeda (1994)
10.1073/PNAS.86.12.4614
Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.
N. Dracopoli (1989)
10.1182/BLOOD.V97.11.3574
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
M. Baer (2001)
Somatic instability of the APC I1307K allele in colorectal neoplasia.
R. Gryfe (1998)
10.1002/path.892
Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer
M. Rubin (2001)
10.1111/j.1365-2141.1992.tb04558.x
Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi‐centre study
M. V. van't Veer (1992)
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C. Boland (1998)
10.1309/AJ84-50AK-1X1B-1Q4C
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.
H. A. Lehr (2001)
10.1093/JNCI/94.4.252
Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
M. Thun (2002)
10.1126/science.271.5249.659
Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis
L. Mao (1996)
10.1016/S0002-9440(10)65436-3
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.
R. Dolcetti (1999)
10.1016/S0145-2126(01)00087-X
Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific.
D. Stirewalt (2001)
10.1038/bjc.1996.393
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
S. Withoff (1996)
Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.
E. Paietta (1994)
10.1016/S0140-6736(00)03258-X
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
S. Narod (2000)
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
D. Lee (1997)
Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.
R. A. Herbst (1994)
10.1002/path.924
An introduction to arrays
N. Maughan (2001)
10.1056/NEJM200006293422603
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
G. Steinbach (2000)
10.1111/j.1749-6632.2000.tb06582.x
A Review of Studies on the Detection of Mutated KRAS2 Sequences as Tumor Markers in Plasma/Serum of Patients with Gastrointestinal Cancer
G. Sorenson (2000)
General Haematology Task Force of BCSH. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders
RM Rowan (1994)
10.1002/ART.1780110306
Detection of nuclear antigens (DNA) in normal and pathologic human fluids by quantitative complement fixation.
E. Barnett (1968)
10.1043/1543-2165(2001)125<471B:IR>2.0.CO;2
The total test approach to standardization of immunohistochemistry.
C. Drachenberg (2001)
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
G. Sorenson (1994)
10.1093/HMG/10.7.657
Tissue microarray technology for high-throughput molecular profiling of cancer.
O. Kallioniemi (2001)
10.1001/JAMA.1997.03540360065034
Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2
W. Burke (1997)
10.1093/AJCP/106.4.457
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.
A. Tefferi (1996)
10.1016/S0002-9440(10)64988-7
Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
E. Remstein (2000)
10.1002/CYTO.10131
CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
D. Kingma (2002)
10.1086/301755
Genotype-phenotype relationships in ataxia-telangiectasia and variants.
S. Gilad (1998)
10.1002/HUMU.10206
Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer
J. Bernstein (2003)
10.1016/S0002-9440(10)64948-6
API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products.
M. Motegi (2000)
10.1002/ijc.10102
TCL‐1, MTCP‐1 and TML‐1 gene expression profile in non‐leukemic clonal proliferations associated with ataxia‐telangiectasia
H. Chun (2002)
10.1159/000028401
The Role of Pharmacogenetics and Pharmacogenomics in Cancer Chemotherapy with 5-Fluorouracil
R. Diasio (2000)
10.1093/HMG/10.20.2253
Fanconi anemia and DNA repair.
M. Grompe (2001)
10.1097/00000658-200006000-00003
Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma.
W. Li (2000)
Current applications of genetic technology in predisposition testing and microsatellite instability assays.
M. Frazier (2000)
Telomerase activity in human solid tumors. Diagnostic utility and clinical applications.
M. Vasef (1999)
10.1586/14737159.1.1.53
Molecular profiling of tissue samples using laser capture microdissection
C. J. Best (2001)
10.7326/0003-4819-71-4-747
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?
F. Li (1969)
10.1002/HUMU.10158
Comprehensive scanning of the ATM gene with DOVAM‐S
C. Buzin (2003)
10.3109/10520299509108323
K-ras gene mutation related to histological atypias in human colorectal adenomas.
T. Ajiki (1995)
10.1093/clinchem/45.8.1148
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications.
I. Bieche (1999)
Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.
G. Steiner (1996)
10.1126/science.270.5235.467
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
M. Schena (1995)
10.1002/JSO.10026
A rational approach to internal mammary node biopsy in the era of lymphatic mapping for breast cancer
K. Kern (2002)
10.1038/nrc972
Screening for lung cancer: in pursuit of pre-metastatic disease
J. Mulshine (2003)
Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
M. Ferrero-Poüs (2000)
10.1038/NG0397-307
Heterozygous ATM mutations do not contribute to early onset of breast cancer
Michael G. FitzGerald (1997)
10.1101/GAD.10.12.1433
Biochemistry and genetics of eukaryotic mismatch repair.
R. Kolodner (1996)
10.1111/j.1600-0609.1998.tb00995.x
Clinico‐prognostic relevance of quantitative immunophenotyping in B‐cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins
S. Molica (1998)
10.1172/JCI118738
Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.
H. Tsukamoto (1996)
10.1093/NAR/26.23.5343
DSEF-1 is a member of the hnRNP H family of RNA-binding proteins and stimulates pre-mRNA cleavage and polyadenylation in vitro.
P. Bagga (1998)
10.1083/JCB.127.6.2061
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton
J. Huelsken (1994)
10.1053/HP.2000.8048
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
J. Seidman (2000)
10.1056/nejm198807283190411
Infection with human T-cell leukemia virus type I in patients with leukemia.
G. Minamoto (1988)
Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization.
A. L. Cheung (1999)
10.1038/sj.bjc.6690033
Tumour markers of prognosis in colorectal cancer
H. McLeod (1999)
10.1097/00062752-200007000-00003
Detection of minimal residual disease in acute leukemia
E. Sievers (2000)
Rearrangements fo the BCL6 gene in diffues large cell non-Hodgkin's lymphoma
F LoCoco (1994)
Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
M. Ladanyi (1994)
10.3892/IJO.17.6.1165
Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review).
J. Weisberger (2000)
Colorectal carcinomas and PTEN/MMAC1 gene mutations.
G. Dicuonzo (2001)
Hypermethylation of the hMLHl Promoter in Colon Cancer with Microsatellite Instability 1
J. Cunningham (2006)
10.1053/GAST.1997.V113.PM9322509
Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer.
P. Peltomäki (1997)
Multiple genetic alterations distinguish distal from proximal colorectal cancer
S Olschwang (1989)
10.1136/BMJ.324.7344.1018
Science, medicine, and the future: Bioinformatics.
A. Bayat (2002)
10.1007/BF02076190
Role of nonpolypoid neoplastic lesions in the pathogenesis of colorectal cancer
T. Matsumoto (1994)
10.1038/sj.cr.7290104
Telomere and telomerase in oncology
J. Mu (2002)
10.1046/j.1365-2141.1999.01439.x
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies
J. F. Dimartino (1999)
10.1053/BEHA.2001.0193
Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
J. San-Miguel (2002)
Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis.
G. Bardi (1993)
10.1093/JNCI/89.12.857
Clonal genetic alterations in the lungs of current and former smokers.
L. Mao (1997)
10.1177/00359157740676P115
The Polyp-Cancer Sequence in the Large Bowel
B. Morson (1974)
10.1002/ijc.10263
High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis
R. von Knobloch (2002)
10.1038/328614A0
Localization of the gene for familial adenomatous polyposis on chromosome 5
W. Bodmer (1987)
10.1093/nar/25.13.2595
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)
N. Kim (1997)
10.1093/HMG/7.12.1907
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.
R. Houlston (1998)
10.1016/S0272-2712(18)30229-4
Cytogenetics. An evolving role in the diagnosis and treatment of cancer.
A. Glassman (1997)
10.1093/AJCP/111.4.467
Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases.
H. Khalidi (1999)
10.1159/000399157
Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma.
G. Henle (1975)
10.1038/ng879
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H. Meijers-Heijboer (2002)
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
S. Thibodeau (1998)
10.1016/S0959-8049(97)85196-9
Lymphatic mapping and sentinel node biopsy
O. Nieweg (1997)
10.1016/S0002-9440(10)64952-8
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
T. Järvinen (2000)
10.1016/S1470-2045(01)00519-8
Lymph-node metastases in patients with melanoma: what is the optimum management?
K. Fife (2001)
Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening.
M. Telatar (1996)
10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H
Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lung
Steven A. Ahrendt (2001)
Downregulation ofhnRNP A2/Bl Expression
M Garayoa (2003)
10.1016/S0272-2712(18)30075-1
Chromosomal abnormalities in acute leukemias.
A. Glassman (2000)
10.1016/0092-8674(81)90022-2
Identification of deletion mutations and three new genes at the familial polyposis locus
G. Joslyn (1991)
10.1159/000055405
The Predictive Value of HER2 in Breast Cancer
M. Piccart (2001)
10.1093/emboj/17.1.325
Interstitial deletions and intrachromosomal amplification initiated from a double‐strand break targeted to a mammalian chromosome
E. Pipiras (1998)
Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
X. Zhou (2000)
10.1200/JCO.1998.16.6.2253
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
J. Gershenwald (1998)
10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F
Unlocking the archive – gene expression in paraffin‐embedded tissue
F. Lewis (2001)
A national cancer institute workshop on microsatellite instability for cancer detection and fami lial predisposition: development
CR Boland (1998)
10.1128/MCB.21.10.3445-3450.2001
Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation
B. Xu (2001)
10.1182/BLOOD.V98.4.979
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
M. Stetler-Stevenson (2001)



Semantic Scholar Logo Some data provided by SemanticScholar